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Abstract 
Background: Worldwide obesity has more than doubled since 1980 and is the fifth 
leading cause of death (1). Obesity is a risk factor for the occurrence of obstructive sleep 
apnoea syndrome (OSAS) (2). The incidence of OSAS in the USA is reported to be between 
9 to 26% with the incidence in the surgical population reportedly being higher (3, 4). 
Obesity and OSAS have implications for the anaesthetic management of patients. It is 
important for the anaesthesiologist to know the occurrence of obesity and risk of OSAS in 
the patient population presenting for surgery (5, 6). 
Aim: The aim of this study was to describe the occurrence of obesity and risk of OSAS in 
adult, elective surgery patients at an academic hospital. 
Method: A descriptive, contextual, prospective study design was used. The height, 
weight, used to calculate the BMI, and neck circumference, used as part of the STOP-
BANG questionnaire, were taken by the researcher. The STOP-BANG questionnaire was 
used to assess for risk of OSAS in all patients. 
Results:  The study included 250 patients of which 153 (61%) were female and 97 (39%) 
were male. There were 223 (89.2%) black patients, 15 (6.0%) coloured, 10 (4.0%) white 
and 2 (0.8%) Indian patients. Of these patients 81 (32.4%) had a BMI of ≥ 30 (95% CI 26.6-
38.2%) and were classified as obese. There were 69 (45.1%) obese females and 12 (12.4%) 
obese males. A STOP-BANG score of < 3 was attained by 205 (82%) patients and ≥ 3, 
indicating a risk for OSAS, by 45 (18%) patients of which 22 (48.9%) had a BMI of < 30 and 
23 (51.1%) a BMI ≥ 30. Chi-square tests revealed statistically significant relationships 
between obesity and gender with a lower BMI being associated with being male (χ2 [1] =  
29.03, p = 0.001), and age younger than 40 years (χ2 [1], p = 0.001). Chi-square tests 
revealed statistically significant relationships between BMI and risk of OSAS, with lower 
risk being associated with a lower BMI (p = 0.003). A lower risk of OSAS was also 
associated with being female (p = 0.004) and a higher risk of OSAS was associated with 
being ≥  than 40 years of age (p = 0.001).  
 Conclusion: Obesity is a multi systemic disease which carries significant morbidity and 
mortality.It is not only  important to identify the disease but also to grade its severity and 
assess the degree of dysfuction it has caused so that the patient can be optimally 
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assessed by the anaesthetist. Our study showed a occurrence of obesity of 32.4% which 
was comparable with the highest prevalences in the world. This should however be 
intepreted with caution as the study may not be generalisable to other communities.  
 
OSAS too is associated with a higher morbidity and mortality. It goes undiagnosed or 
under-diagnosed in a large proportion of patients,  and poses increased anaesthetic risk. 
It should be screened for and identified as well as it’s severity graded in order to institute 
appropriate anasthetic management and make plans for post operative care in a 
specialised environment. The risk of OSAS was found to be 18% in our study. It was found 
to be higher in males, and age older ≥ 40. Although there was a high occurence of obesity 
in the females there was a lower risk of OSAS. The risk of OSAS was similar in obese and 
non obese patients.  
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Chapter One: Overview of the study 
1.1 Introduction 
In this chapter the background, problem statement, aims and objectives, research 
assumptions, demarcation of study field, ethical considerations, research methodology, 
significance, validity and reliability, and an outline of this study will be discussed. 
1.2 Background 
The World Health Organisation (WHO) emphasized that obesity is becoming a major 
health problem in developing countries. (7) The WHO rates obesity as the fifth leading 
risk for death worldwide and an estimated 2.8 million adults die each year as a result of 
being overweight or obese. Furthermore being overweight and obese account for 44% of 
the diabetes burden, 23% of the ischaemic heart disease burden and between 7 to 41% of 
cancers. About 65% of the world’s population lives in countries where being overweight 
and obese kills more people than being underweight. Worldwide obesity has more than 
doubled since 1980. In 2008, more than 1.4 billion adults, 20 years and older, were 
overweight. Of these over 200 million men and nearly 300 million women were obese. (7) 
Obesity is associated with a constellation of complications including insulin resistance and 
type 2 diabetes (8, 9), dyslipidaemias (10, 11), cardiovascular disease, which includes 
hypertension, heart disease and stroke (12), gallbladder disease (13), osteoarthritis (14), 
kidney disease (15), cancer (16) and respiratory complications (17, 18).  
  
Obstructive sleep apnoea syndrome (OSAS) is a well described association of obesity (2, 
19). Its incidence is reported to be between 9 to 26%. The majority of these studies were 
done in the United States (3, 4, 20). Finkel et al (4) found 23.7% patients who screened 
high risk for OSAS in the surgical population of whom 82% were undiagnosed. This has 
serious consequences as untreated OSAS has been linked to increased mortality (3, 21). 
There are numerous scales available to assess risk for OSAS, for example Epworth Sleep 
Scale, Berlin score, American Society of Anesthesiologists scoring system and STOP BANG 
questionnaire. The STOP-BANG questionairre (22, 23) is a validated score that has been 
used in surgical patients to predict risk of OSAS.   
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Obesity and OSAS pose a challenge for the anaesthetist as various anaesthetic 
considerations come into play. Pharmacokinetics is altered in obesity (24-26), airway 
management is potentially difficult, as is positioning of patients. Lung ventilation 
strategies are different, regional blocks are technically more difficult and may carry a 
higher rate of complications (27). Peri-operative monitoring is therefore more important 
in these patients (27, 28). OSAS carries its own set of associated co-morbidities. These 
include cardiovascular disease and stroke and a higher rate of post operative 
complications, longer hospital stays and specialised intensive care management (29-31). 
These patients also suffer an increased morbidity and mortality, thus obesity and OSAS 
are important risk factors to illicit pre operatively so that appropriate peri-operative 
management is implemented (32, 33). 
1.3 Problem statement 
Obesity is associated with increased co-morbid conditions and increased morbidity and 
mortality among patients undergoing surgery. (34) OSAS is associated with further peri-
operative morbidity and mortality (29), and is under diagnosed in a large number of 
patients.(3, 5, 20) Finkel et al (4) in 2009 described an 82% prevalence of undiagnosed 
OSAS among American adults presenting for surgery.  Obesity and OSAS have implications 
for the anaesthetic management of patients (25, 28, 30, 35, 36). It is therefore important 
for the anaesthetist to know the occurrence of obesity and OSAS in the patient 
population presenting for surgery. 
The occurence of obesity and the risk of OSAS among patients at Chris Hani Baragwanath 
Academic Hospital (CHBAH) who present for elective surgery is unknown.  
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1.4 Aim and objectives 
1.4.1 Aim 
The aim of this study was to describe the ocurrence of obesity and risk of OSAS in adult 
patients going for elective surgery at the J.D. Allen and the Gynaecology Theatre Complex, 
at CHBAH. 
1.4.2 Objectives 
The primary objectives of this study were to: 
 describe the BMI of adult patients undergoing elective surgery   
 describe the risk of OSAS using the STOP BANG questionnaire.   
 
The secondary objectives of this study were to: 
 compare the BMI with the risk of OSAS 
 compare the BMI with gender 
 compare the BMI with age 
 compare the risk of OSAS with gender  
 compare the risk of OSAS with age. 
1.5 Research assumptions 
The following definitions will be used in this research.  
Adult: is defined as a person 18 years or older.   
Obesity:  is defined by a BMI greater than or equal to 30 kg/m2.(37) 
 STOP-BANG questionnaire: is a validated questionnaire (Appendix 1) comprising of eight 
questions which assess the risk for OSAS in patients. (22, 23)  
1.6 Demarcation of study field 
This research was conducted at CHBAH, a  central hospital located in Soweto,  
Johannesburg and affiliated to the University of Witwatersrand. The hospital has an 
4 
 
estimated 2 888 beds and 26 theatres in eight theatre complexes and on average 65 000  
surgical procedures are completed per year. (38)  
1.7 Ethical considerations 
Permission was obtained from the relevant authorities to conduct this study.   
Adult patients presenting for elective surgery were invited to take part in the study. The 
researcher explained the study to the patients and those agreeing to participate received 
an information letter (Appendix 2) and were asked to sign informed consent (Appendix 3). 
Anonimity and confidentiality were ensured. If a patient was concerned about their 
weight, they were referred to the dietetics department at CHBAH.    
This study was carried out in accordance with The Declaration of Helsinki (39) and the 
South African Good Practice Guidelines (40). 
1.8 Research methodology 
1.8.1 Research design 
A prospective contextual, descriptive study design was utilised. 
1.8.2 Study population 
The study population will be adult patients presenting to CHBAH for elective surgery in 
various disciplines. 
1.8.3 Study sample 
In consultation with a bio-statistician, using nQuery Advisor, a sample size of 250 patients 
was determined and a convenience sampling method was used. Inclusion and exclusion 
criteria were used to select suitable participants for the study. 
1.8.4 Data collection 
Data was collected over a 16 day period. The patient’s heights, neck circumferences and  
weights were measured by the reseacher using the same equipment and identical 
methods in order to standardise the results. 
5 
 
1.8.5 Data analysis 
All data recorded was captured on a Microsoft Excel spread sheet. The data was analysed 
in consultation with a bio-statistician. 
1.9 Significance of the study 
Obesity is often associated with a more complicated anaesthetic management plan and 
increased morbidity and mortality. (28) It is also associated with a constellation of co-
morbidities (10).  This study may create awareness around obesity allowing the 
anaesthetic management of these patients to be optimised. OSAS is largely undiagnosed, 
the consequences of which can be catastrophic, as these patients need individualised and 
specialised perioperative care (29, 31).  
This study was the first to determine the occurence of obesity and risk of OSAS in the 
adult surgical population at CHBAH. The results of this study may increase anesthetists 
awareness of obesity and the risk of OSAS in this population.   
1.10 Validity and reliability 
Measures were taken to ensure the validity and reliability of this study.   
1.11 Study outline 
The outline of this study is as follows. 
 Chapter 1: Overview of the study 
 Chapter 2: Literature review 
 Chapter 3: Research methodology 
 Chapter 4: Results and discussion 
 Chapter 5: Summary, limitations, recommendations and conclusion 
1.12 Summary  
In this chapter an overview of the background, problem statement, aims and objectives, 
research assumptions, demarcation of study field, ethical considerations, research 
methodology, significance, validity and reliability, and study outline were discussed. 
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Chapter Two: Literature review 
2.1 Introduction 
In this chapter the literature pertaining to the definition and prevalance of obesity, the 
pathophysiology, risk factors, diagnosis of obesity, risk factors related to obesity and the 
anaesthetic considerations of the problem shall be discussed. OSAS literature will also be 
discussed with regards to pathophysiology, risk factors, diagnosis of OSAS and anaesthetic 
management. 
2.2 Obesity  
2.2.1 Definition of obesity 
Obesity is a chronic disease consisting of an increase in body fat stores. The word obesity 
comes from the Latin word ob-esum, meaning on account of having been eaten, and this, 
partly, is what leads to this disease. Obesity arises when the caloric intake exceeds the 
energy expenditure in an individual. The body mass index (BMI) is a value used to classify 
obesity. A BMI greater than or equal to 30 kg/m2 is considered obese. (1, 27)  
A complex set of interactions come into play between genetics, behaviour, environment, 
culture and socioeconomic status that lead to obesity. People may make decisions based 
on their enviroment, the decision to walk rather than use motor vehicles or public 
transport may be due, for example, to their environment being deemed unsafe. Genetics 
has also been found to have a direct link to obesity. Diseases and drugs further contribute 
to obesity. Endocrine disorders including Cushing’s disease and hypothyroidism may lead 
to weight gain and obesity as may polycystic ovarian syndrome. The side effects of drugs 
like antidepressants and steroids can also cause weight gain. (1, 27, 41)  
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2.2.2 Prevalence 
International prevalence 
The WHO reports that one in ten of the world’s population is obese. The prevalence of 
obesity has more than doubled since 1980. In 2008 more than 1.4 billion adults above the 
age of 20 were overweight. Of these 200 million men and 300 million women were obese. 
(1) 
In the United States of America (USA) the Centers for Disease Control and Prevention 
(CDC) estimated that 35.7% of USA men and women were obese in 2009 to 2010. There 
was no significant difference between the prevalence among males (35.5%) and females 
(35.8%) (42). In 2013 the prevalence was quoted as being 34.9% (43). 
The National Health Statistics (NHS) survey in The United Kindgom in 2012 found 26% of 
both men and women obese (44). Data from 2013 showed that in Canada 22% of males 
and 20% of females were obese, in Belgium 20% of males and 21.7% of females were 
obese and in Mexico 24.2% of males and 34.5% of females were obese. (45, 46) Table 2.1 
below shows the prevalence of  obesity in some other countries outside Africa. 
Table 2.1  Prevalence of obesity in countries outside Africa 
Country Year of 
survey 
Age National prevalence of obesity (%) 
Males Females Total 
Australia (47) 2004-5 18-100 18% 17% 17.5% 
Japan (48) 2004 15-100 2.9% 3.3% 3.1% 
Brazil (49) 2002-3 20-100 8.90% 13.10% 11.10% 
China (49) 2002 18-100 2.4% 3.40% 4.9% 
India (37) 2005-6 15-49 1.30% 2.80% 2% 
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African prevalence 
The prevalence across Africa varies considerably from as little as 2.1% in Madagascar and 
2.3% in Gambia to as much as 30.3% in Egypt. Table 2.2 shows some African countries and 
their rates of obesity (7). Some of this information may seem outdated but these 
countries do not regularly update their data. 
Table 2.2 Prevalence of obesity in some African countries (7) 
Country Year Prevalence (%) 
Egypt 2006 30.3% 
Tunisia 1996-1997 17.2% 
Morocco 2000 16% 
Zimbabwe 2005 15.7% 
Mauritius 2002 14.4% 
Ghana 1998 3.1% 
Gambia 1997 2.3% 
Madagascar 1999 2.1% 
 
South African prevalence 
In 1998 The South African Demographic Health Survey was undertaken and published in 
2002. This demonstrated 29% of men and 56% of women being classified as overweight 
or obese. This was unusual as the prevalence in most other countries showed a higher 
incidence of obesity in males (50, 51). In a sample of 7726 South African women aged 15 
to 95 years old the highest prevalence of overweight and obesity was found in black 
women (58.5%), followed by women of mixed ancestry (52%), white women (49.2%) and 
Indian women (48.9%). In a sample of 5401 men aged 15 to 95 years the prevalence of 
overweight and obesity was highest in white men (54.5%), followed by Indian men 
(32.5%), then men of mixed ancestry (31%) and the lowest prevalence among African 
men (25%) (50). 
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In 2012 the World Federation of Obesity released statistics from the South African 
National Health and Nutrition Examination Survey, indicating that in South Africa 10.6% of 
males and 39.2% of females were found to be obese (46). 
2.3 Pathophysiology of obesity 
Obesity is a disorder of supply and demand. When the intake of calories exceeds its 
utilisation, obesity ensues. Obesity should be viewed as a systemic disease with multiple 
effects in the body. Its pathogenesis is complex and interlinked. It is caused by impaired 
regulation of lipid metabolism and lipid toxicity. Genetic and environmental factors are 
also thought to play a role. The regulation of appetite and satiety is impaired.  Pathologies 
linked to obesity include dyslipidaemia, impaired glucose metabolism, secretion of 
adipokines, hypertension and atherosclerosis. The pathophysiology of obesity and 
reasons for these associations will be discussed in more detail. (34, 52, 53) 
Dysregulation of lipid metabolism and lipid toxicity 
 In obesity there is excess caloric intake and a supply that exceeds the demand. Free fatty 
acids, which in normal individuals are stored in fat cells as triacylgylcerols, are now freely 
circulating in the blood. This is a result of increased lipolysis stimulated by the 
sympathetic state which occurs in obesity. Lipotoxicity occurs as the lipids and their 
metabolites cause oxidative stress, particularly to the mitochondria and endoplasmic 
reticulum. Lipogenesis is inhibited by excessive free fatty acids release resulting in 
inadequate clearance of serum triacylglycerol. This then contributes to 
hypertriglyceridemia. (52, 53) 
Insulin resistance and hyperglycaemia 
There are a few contributing mechanisms to insulin resistance. Release of free fatty acids 
from lipoproteins by lipoprotein lipase causes lipotoxicity and resulting insulin receptor 
dysfunction and insulin resistance. This creates hyperglycaemia. Hyperglycaemia is 
compensated for by increased hepatic gluconeogenesis. Increased hepatic production of 
glucose further causes hyperglycaemia aggravated by insulin resistance. Fat associated 
macrophages, secreted by adipocytes, that secrete monocyte chemoattractant protein-1, 
macrophage migration factor and restin all decrease sensitivity to insulin and thus insulin 
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resistance. Lipotoxicity also decreases secrection of beta cell insulin eventually resulting 
in cell exhaustion. (52, 53) 
Adipokines 
In order to further understand the pathophysiology, adipocytes must be thought of as 
endocrine organs. White adipose tissue secrete a variety of adipokines. Inflammatory 
adipokines together with free fatty acids cause diffuse inflammation. Inflammatory 
markers that are raised in obesity include tumour necrosis factor alpha (TNF α), 
interleukin 1, and interleukin 6. Acute phase proteins also upregulated include C-reactive 
protein and the specific amyloid antigen. These inflammatory markers that are increased 
in obesity contribute to inflammatory conditions such as those in the bronchial tree of 
patients with OSAS. Visceral adipokines are transported by the portal system to the liver. 
This then enhances non-alcoholic steatohepatitis.  Adipose cells secrete anti-
inflammatory secretagogues such as adiponectin and visfatin. These hormones are meant 
to counteract the pro-inflammatory adipokines, enhance insulin sensitivity, improve 
vascular endothelium dysfunction and are anti-inflammatory and anti-atherogenic. (53) 
Hypertension 
Adipokines cause increased vasomotor tone by secreting renin, angiotensinogen and 
angiotensin II. These substances are similar to those secreted by the renal renin 
angiotensin system and enhance hypertension when secreted by adipocytes. (34) 
Atherosclerosis 
In addition to insulin resistance the pro-inflammatory state causes, obesity also 
perpetuates the development of atherogenesis. White adipose tissue secretes endothelial 
modulators which include vaso active endothelial growth factor, plasminogen activator 
inhibitor-1, angiotensinogen, renin and angiotensin, which in addition to contributing to 
impaired vasomotor tone and hypertension also causes endothelial dysfunction. Later as 
atherosclerosis progresses with macrophage and smooth muscle infiltration there is the 
additional secretion of cytokines like monocyte chemoattractant protein-1, macrophage 
migration factor, and endothelin-1. These enhance the inflammation that occurs in the 
vascular walls containing the athersclerotic plaques which are inflammatory lesions. 
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Adipokine procoagulants causing thrombosis include plasminogen activator inhibitor-1. 
Interleukin-6, tumour growth factor β and TNF α. These cause thrombosis, especially from 
ruptured atherosclerotic plaques. Matrix metalloproteinases, also secreted from 
adipocytes, lead to the progression of athersclerotic changes in vesssels with the 
propagation of plaque formation and the collagen remodeling. This then causes a 
thinning of the atheroma cap and the release of tissue factor which futher propagates 
thrombosis. (34) 
2.4 Risk factors of obesity  
Numerous risk factors have been associated with obesity. These include genetics, 
intrauterine and early life influences, diet, physical activity, age, gender, socio-economic 
and cultural factors, education, parity, and stress. (54-57) 
Genetics 
Biologists believe that genes have a direct link to obesity, evidenced by disorders like 
Bardet–Biedl syndrome, a ciliopathic genetic disorder that produces many effects 
including obesity, retinis pigmentosa, polydactylly, hypogonadism and renal failure. 
Prader–Willi syndrome, a rare genetic disorder of chromosome 15 characterised by low 
muscle tone, short stature, incomplete sexual development, cognitive disabilities and a 
chronic hunger leads to over eating and obesity. 
The human gene map has approximately 127 genes with at least a single phenotypical 
relationship to obesity. These genes include ACE, ADIPOQ, ADRB2, ADRB3, DRD2, GNB3, 
HTR2C, IL6, INS, LDLR, LEP, LPER, LIPE, MC4R, NR3C1, PPARG, RETN ,TNFA, UCP1, UCP2, 
UCP3 and VDR. Bouchard (54) suggests five major types of genotypes that are associated 
with obesity. They are as follows 
 “a thrifty genotype which is associated with a low metabolic rate and insufficient 
thermogenesis. 
 a hyperphagic genotype which is associated with poor regulation of appetite and 
satiety and a tendency to overfeed. 
 a sedens genotype with a propensity to physical inactivity. 
 a low lipid oxidation genotype and 
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 an adipogenesis genotype which is associated with the ability to expand 
adipocytes which have a high lipid storage capacity.” 
Therefore there is strong evidence for a genetic component to obesity. (57, 58) 
Intrauterine and early life influences 
There is evidence linking adverse intrauterine environment to chronic diseases later in 
life. Rogers (55) suggests an element of intrauterine programming, where the effects of 
diabetes, smoking or even famine conditions in utero can affect future BMI.  There is an 
association between birthweight and BMI in later life. This study shows that the higher 
the birthweight the greater the chance of a higher BMI and thus obesity. The prenatal and 
neonatal period may be critical for the development of obesity. A higher birth weight may 
be associated with a more favourable intrauterine environment with a few exceptions for 
example foetal macrosomia found in diabetic women. Ong (59) conversely showed that a 
low birth weight is associated with an increased risk of obesity, insulin resistance, and 
cardiovascular disease in adults. (55, 59, 60) This may be explained by the fact that foetal 
metabolic and hormonal responses to intrauterine growth restraint followed by rapid 
postnatal growth  responses are a predispostion to obesity. There are a few hypotheses 
proposed as to the link between low birthweight and adulthood disease. The thrift type 
phenotype hypothesis proposes that maternal-foetal undernutrition could result in long 
term programming change in metabolic or hormonal activity involving insulin and insulin 
like growth factors predisposing to diabetes. The foetal insulin hypothesis proposes that 
children born with low birthweights inherit mutations in the genes coding for glucokinase 
and insulin secretion and this may be responsible for maturity onset diabetes. The 
surviving small baby/thrifty genotype hypothesis proposed that low birthweight infants 
are at an increased risk of mortality and this could demonstrate an increased risk of 
diseases and are genetically predisposed to disease but due to better health care they 
survive to demonstrate this disease in adulthood. (54, 55, 59, 61) 
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Diet 
With increased urbanisation a more Westernised diet has been adopted. One of the 
pertinent features of this is increased fat intake, these dietary changes contribute to 
obesity (56). The more urbanised communities become, the higher their rate of obesity. 
In urbanised settings food, high in fat, is cheaper and more easily available (62). The 
South African National Health and Nutritional Examination Survey (63) also provided 
information about the relationship between diet, nutritional status and health in the 
South African population. It showed that there was a worsening in nutritional status in 
males and females based on anthropometric measurements including BMI, waist 
circumference, and waist-hip ratio. 
This survey identifed the concept of food security that is defined as, “ a condition which 
exists when all people at all times have physical, social, and economic access to sufficient, 
safe and nutritious food that meets their dietary needs”. The South African National 
Health and Nutrtional Examintion Survey also showed that only 45.6% of the population 
was food secure while 28.3% were at risk for hunger and a further 26% experienced 
hunger and were thus food insecure. The study further showed that the largest 
percentage of participants who experienced food insecurity were either from urban 
informal or rural formal settlements. This demonstrates the lower household income in 
these areas and thus less money available to be spent on food, leading to unhealthy but 
cheaper food sources, mainly starches such as maize, rice and bread, being the mainstay 
with little dietary diversity and lower amounts of fruit vegetables and protein as these are 
more expensive products.  The amount of fat consumed by urban formal areas was 
significantly higher than that of rural informal areas. A higher sugar and salt intake also 
seen more in urban formal settlements increases the risk of obesity, although urban 
residents health and nutrition knowledge was deemed to be better. People living in rural 
or informal areas ate less fruit and vegetables than their urban counterparts. This leads to 
dietary deficiences in vitamins A and C, folate and potassium and inadequate intake of 
dietary fibre. This may be due to the lack of access and availability of fruit and vegetables 
in poorer communities such as informal settlements. (63) 
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Poor dietary diversity is found in many African countries and is not restricted to South 
Africa. Bouchard (54) quotes the development of an “obesogenic” environment which 
favours consumption of large portion size meals, high fat diets and many hours spent 
watching television or sitting with little physical activity. This is also fueled by media 
pressure and advertisments enticing consumers to consume more food. High fat and 
sugary foods are designed with enhanced flavour making them more desirable than 
healthier natural choices. (63)  
Physical activity 
Physical inactivity is recognised as the fourth leading risk factor for mortality and is 
responsible for 6% of all deaths according to the WHO and is a risk factor for non 
communicable diseases such as cancer, diabetes and cardiovascular disease. It is 
estimated that six out of 10 deaths are attributable to physical inactivity and that non 
communicable diseases are responsible for nearly half of the overall burden of disease. 
(64) There are a number of well documented effects of physical activity. It increases 
energy expenditure, is associated with better dietary adherence to weight loss and better 
long term weight loss management (65). The use of labour saving mechanical devices 
decreases energy expenditure. Urban communities engage in more passive 
entertainment such as television watching and less physical activity (62). South Africans in 
general have a low level of physical activity and this is one of the predictors of obesity 
(56). In the South African National Health and Nutrition Examination Survey in 2012 two 
thirds (62.4%) of males were found to be physically fit, while 27.9% tested unfit (63). A 
significantly lower number of the females tested were physically fit (42%) while a similar 
number (45.4%) were unfit. This demonstrates the high level of physical unfitness among 
the population especially the females. The South African National Health and Nutrition 
Examination Survey demonstrated that informal and formal urban settlements displayed  
differences in terms of fitness. Their study displayed that 51.4% of females surveyed in 
the informal settlements were found to be fit compared to only 33.9% in the formal 
settlements. This can possibly be explained by the higher level of physical activity in 
informal urban settlements, most of which is carried out by females. A higher percentage 
of males were found to be fit in both urban formal (57.2%) and urban informal 
settlements (74.6%) with a higher level of fitness again being seen in informal 
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settlements. A similar trend was seen in females. In 2003 another study on physical 
fitness confirmed the finding of low levels of physical activity among South Africans (66). 
Gender 
Gender is a known contributer to BMI. The South African National Health and Nutrition 
Examination Survey (63) has shown that South African females were significantly heavier 
than males, 72,2 kg compared to 67.3 kg. Other studies in the South African population by 
Puoane (50) and Kruger (51) have consistently shown a higher occurrence of overweight 
and obesity in females. This phenomenon could be explained by multiple factors including 
socio-cultural factors. Results of a WHO survey showed a similar pattern of a higher mean 
BMI in females in other African countries including Mozambique, Swaziland, Zimbabwe 
and Zambia (67).  
Age 
The trend for physical fitness was found to decrease with age (66). This then leads to an 
increase in BMI with age in modern sedentary societies (68). The South African National 
Health and Nutrition Examination Survey showed that among females there was an 
increase in fitness with age up to a plateau in the region of 30 to 40 years. It was also 
found that in the age groups 45 to 54 years and 55 to 64 years there was a higher mean 
BMI in both males and females when compared to ages between 17 to 24 years.  In 
females the BMI then decreased from 65 years and older.  
Socio-economic and cultural factors 
There are traditional and cultural perceptions which impact on body size and obesity. In 
black communities in South Africa being overweight has many connotations. Research has 
shown that being obese is perceived to reflect affluence, happiness, and even a husband’s 
ability to take care of his wife. Due to the HIV/AIDS epidemic, obesity is perceived to 
reflect people that are healthy and not infected (69). The highest prevalence of obesity in 
The South African National Health and Nutrition Examination Survey was in black African 
females, who are socio-economically disadvantaged. In addition both males and females 
from urban formal areas had a higher mean BMI and were more likely to be obese than 
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those from urban informal or rural areas. This may be related to the level of activity. (54, 
63) 
 Education 
It was found that the highest educated women had the smallest waists followed by those 
women with no education. Older men with between 8 to 12 years of education had 
higher levels of abdominal obesity. This can be accounted for by evidence suggesting that 
the more educated have a better understanding of health education and nutrition. They 
could therefore make more informed choices. Highly educated people also command 
higher salaries and thus have more income available to buy a diverse array of food groups 
that incorporate fruit, vegetables and protein sources into their diet. These individuals are 
also more likely to understand the benefits of exercise and thus more likely to make 
concerted efforts to exercise. Women with no education are often from rural or informal 
settlements and therefore have to do physically challenging jobs and are more active, 
accounting for their smaller waists.  (50, 63) 
Parity 
Parity is associated with obesity, with as much as a 7% increase risk of obesity, in women, 
with each additional child, and 4% in men. This is probably attributed to lifestyle changes 
after the birth of a child with less time available for exercising.(70, 71)  
Stress 
High levels of stress are associated with weight gain. This may be related to endocrine 
changes. (71) Urbanisation itself is reported to produce stress and is thus linked to weight 
gain (7). In many settings obesity was associated with high levels of discrimination and 
stigmatisation contributing to stress (72). People may use food as a form of comfort to 
suppress negative emotions ranging from stress, anger, loneliness and fear to boredom 
(73). 
2.5 Diagnosing obesity 
There are a few common methods of diagnosing the amount of body fat. These include 
skin fold calipers, bioelectrical impedance analysis, anthropometric measurements, 
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hydrostatic weighing and a dual energy X-ray absorptionmetry scan. Many of these 
methods rely on algorithms to convert the measured parameter to an estimate of body 
fat percentage and as such none are perfect. (74-76) 
Skin fold calipers 
This is carried out by “pinching fat” and then measuring the thickness with a body fat 
caliper. The reading is given in millimeters which can then be compared to a chart with 
age and gender to arrive at a body fat percentage. Advantages include that it is easy to do 
and if done correctly is repeatable. The disadvantages include that the operator must be 
experienced and the same area must be used to measure each time or there will be 
variability in measurements. In patients who are overweight or obese the fat may not fit 
into the caliper and thus an erroneous reading will be produced. (74) 
Bioelectrical impedance analysis (BIA): This method uses the opposition of flow of an 
electric current passed through the body to measure fat. Muscle has a higher water 
content and is far more conductive than fat. The impedance along with height and weight 
measurements can be used to estimate body fat percentage . Advantages include it being 
easy to do and inexpensive. Disadvantages are the questionable accuracy variation of 
results depending on the hydration status of the patient. 
In a study by Corral et al (75) between 1988 to 1994, 13 601 subjects in the USA that were 
part of the Third National Health and Nutrition Examination Survey were enrolled. These 
patients who in addition to having their anthropometric measurements taken and BMI 
calculated also had bioelectrical impedance analysis done to estimate body fat 
percentage. The number of patients who met the WHO standard for obesity of body fat 
percentage, which was > 25% in males and > 35% in females, was then compared to the 
BMI range for obesity (BMI ≥ 30). Results showed that, WHO BMI defined obesity, was 
found in 21% of males and 31% of females. Body fat percentage which defined obesity, 
was interestingly found in 50% of males and 62% of females. This shows that actual body 
fat was under diagnosed in a considerable proportion of patients. (74, 75) 
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Hydrostatic weighing 
This provides a measurement of body fat with a small margin of error. It requires being 
submerged in a specialised tank of water. Bone and muscle are denser than water. A large 
amount of fat mass will make the body lighter in water, indicating a higher percent body 
fat. Draw backs to this test are that it is expensive, impractical and accuracy of the 
readings is based on blowing all the air out of the lungs. It also takes 20 to 30 minutes to 
perform. (74) 
 Dual energy X-ray absorptionmetry scan  
 The dual energy X-ray absorptionmetry scan is another accurate method of body fat 
measurement. It is based on a three compartment model that divides the body into total 
body mineral, fat free lean mass and fat tissue mass. The dual energy X-ray 
absorptionmetry scan allows for fat distribution analysis. An advantage of this method is 
its accuracy. Disadvantages are that it is expensive, takes 10 to 20 minutes to complete 
and exposes patients to X-rays, although it is a low dose. (74) 
BMI 
BMI is a form of anthropometric measurement. It is a relatively old tool and was 
developed in the 19th century by Adolphus Quetelet. He made the observation that there 
was a proportional relationship between body weight and the square of the height in 
adults with normal body frames. It is this observation that is still used today and BMI is 
arguably the cornerstone screening test for obesity and widely used for the classification 
of obesity. It is considered an indicator of body fat but in effect is a surrogate measure 
because it measures excess weight rather than excess fat. 
The benefits of using the BMI are that it is simple, inexpensive and non-invasive. It also 
provides a standard and a reference on which prevalence and trends can be based. (76) 
BMI is not without its limitations. BMI can provide misleading information about body fat 
content in instances including childhood and infancy, aging, racial differences and in 
athletes. Numerous factors influence the BMI. There is an increase in the ratio between 
lean body mass and fat in ageing, thus it may underestimate body fat. The BMI was based 
on Caucasian subjects, but certain ethnic groups display different relationships between 
BMI and body fat. BMI gives a poor representation of body fat in muscular people, giving 
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them a high BMI which does not correlate with their body fat content. In exercising 
individuals, BMI will not show them the percentage of fat they are losing or whether the 
weight loss is due to lean body mass being lost. In certain circumstances, like sepsis and 
endocrine abnormalities, that change the relationship between lean and fat tissue is 
altered, and BMI becomes inadequate. On average women also have greater amounts of 
total body fat than men with an equivalent BMI which is not taken into consideration in 
the BMI measurement.  Corral et al’s (75) study showed that although BMI had a high 
specificity it had a low sensitivity. It has limited value in being able to correctly diagnose 
patients with increased body fat, especially in patients between 25 to 30 kg/m2, for men 
and the elderly.  
BMI can be classified  broadly as underweight, normal, overweight or obese. To compute 
this number the individuals weight, in kilograms, is divided by the height, in metres 
squared. Table 2.3 shows the classification of patients using BMI. (68, 76)   
Table 2.3 Classification of BMI (68, 76) 
BMI (kg/m2) 
Underweight <18.5 
Severe <16 
Moderate 16 - 16.99 
Mild 17 – 18.49  
Normal 18.5 – 24.99 
Overweight ≥ 25 
Pre-obese 25 – 29.99 
Obese ≥ 30 
Obese class I 30 – 34.99 
Obese class II 35 – 39.99 
Obese class III ≥ 40 
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2.6 Sequelae of obesity 
Obesity is associated with an increased risk of developing comorbid conditions, some of 
which include, hypertension (77, 78), heart disease (12), diabetes (9), gallstone disease, 
stroke, cancer (16), and psychological complications (70, 72), osteoarthritis (14) and 
respiratory complications (79). 
Obese people are at a higher risk of cardiovascular disease. Abdominal or central obesity 
poses higher risk as visceral fat is more metabolically active producing more inflammatory 
cytokines. There are a variety of interlinked factors that come into play connecting 
obesity to heart disease. At the crux is the development of atherosclerosis. (80) 
Hypertension 
Hypertension has a well described relationship to obesity. The relationship between 
obesity and hypertension is complex and probably represents a multifactorial interplay 
between racial, gender, demographic, genetic, neurohormonal, and other factors. Upper 
body (android) obesity, especially in the presence of increased visceral fat, is more 
strongly associated with hypertension than lower body (gynoid) obesity. The National 
Health and Nutrition Examination Survey showed a relationship between BMI and arterial 
hypertension. The Health Professionals Follow-up study (81) showed that among obese 
men, 35% were hypertensive. The pathophysiology behind the link between obesity and 
hypertension, although not fully understood, is thought to be due to the increased 
intravascular volume and a peripheral vascular resistance that is not able to cope 
appropriately with the added intravascular volume. Obese patients also show an 
increased sodium retention and increased sympathetic activity adding to the 
development of hypertension. The renin-angiotensin-aldosterone system is overactive in 
obesity, further adding to the pathogenesis of hypertension. (77, 78) 
Heart disease 
Obesity is associated with increased risk of heart disease. This may be associated with the 
dyslipidemia, accelerated atherosclerosis and hypertension. Obesity was found to 
independently predict the risk of developing coronary atherosclerosis. Punyadeera et al 
(82) showed a higher rate of coronary heart disease in obese white women compared to 
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obese black women due to the distribution of their fat. This study demonstrated that 
obese black woman had higher levels of visceral fat which contributed to a more 
artherogenic lipid profile and therefore a higher risk of heart disease. The increase in 
stroke volume and cardiac output and hypertension demonstrated in the obese patient 
leave these patients suceptible to left ventricular hypertrophy and dysfunction. The right 
ventricle can also be dysfuctional, either from the left ventricular strain or from the 
prescence of concomittent OSAS and pulmonary hypertension. The person may thus 
present in biventricular failure. (34) 
Diabetes 
Obesity, particularly truncal obesity is closely correlated to the prevalence of diabetes. 
Adipokines including plasma leptin, tumour necrosis factor-α, and free faty acid  levels are 
all elevated in obesity and play a role in causing insulin resistance. When there is beta cell 
dysfunctional, diabetes ensues. Glycaemic control as well as insulin resistence improve 
with a decrease in weight. (9) 
Cancer 
Obesity has been shown to to have a relationship with cancer. Obesity is associated with 
an increased risk of cancers of the oesophagus, pancreas, colon and rectum, breast (after 
menopause), endometrium, kidney, thyroid, and gallbladder. It is estimated that 4% of 
new cases in men and 7% in women were attributed to obesity. Some mechanisms 
proposed for the relationship include elevated levels of oestrogens in females, high levels 
of insulin like growth factor, especially in people with central obesity, which inhibits 
apoptosis and stimulates cell proliferation. Adiponectin could be involved with the risk of 
cancer. Genetics is also involved in the link between obesity and cancer.  (83) 
Gallbladder disease 
Cholelithiasis is one of the primary hepatobiliary pathologies associated with obesity. The 
risk of having gallbladder disease is about twice as high in obese women as compared to 
normal weight women. The pathogenesis of gallbladder disease is postulated to be higher 
plasma concentrations of cholesterol and triglycerides . This concentration of fatty 
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substances is in excess of bile acids leading to precipitation of cholesterol gallstones in the 
gallbladder. (34, 53) 
Stroke 
There is a positive relation between obesity and both ischaemic and haemorrhagic stroke, 
independently of other risk factors including diabetes, hypertension and dyslipidemia. 
Plasma leptin may be the link between haemorrhagic stroke and obesity. Obese patients 
have a high level of leptin in plasma and lepin restistance as leptin may play a role in the 
activation of immune cells and cytokines accelarating atherosclerosis. (80) 
Osteoarthritis 
The occurrence of osteoarthritis is increased in overweight individuals. In the knees and 
ankles it may be directly related to the trauma associated with excess body weight and 
the effects of inflammatory adipokines on the joint synovium and function of muscle. (10, 
18, 34) 
 Respiratory complications of obesity 
Adverse effects of obesity include exertional dyspnoea, limited exercise capacity, and 
adverse effects in pulmonary mechanics. More importantly, it can result in sleep 
disordered breathing including OSAS and obesity related respiratory failure. Obesity has 
deleterious effects on the mechanics of the lung. BMI has a relationship with the degree 
of airway resistance and work of breathing and is inversely related to thoracic lung 
volumes. A reduction in functional residual capacity and expiratory reserve volume are 
associated with early airway closure and resultant gas trapping causing ventilation 
perfusion mismatching and hypoxia. Obesity also imposes a restriction defect due to mass 
effect on the chest wall with decreased compliance. Studies in anaesthetised obese 
patients have demonstrated a relationship between the degree of obesity and static lung 
compliance due to reduction of functional residual capacity. Breathing at low lung 
volumes causes expiratory flow limitation due to early airway closure which generates 
positive pressure causing increased work of breathing. All these changes are further 
exaggerated during sleep due to the negative impact of the supine position on the 
mechanics of breathing. (84-86) 
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Psychological complications of obesity 
There is much stigma associated with being overweight (87). This can lead to body image 
issues, unhappiness, and disordered eating. Obese woman appear to be at greater risk of 
psychological dysfunction than obese men. This is possibly due to societal pressures to be 
thin (88). Obese individuals have abnormalities in health related quality of life (89). 
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2.7 Anaesthetic considerations in obesity 
Obesity is a systemic disease and as such has a variety of anaesthetic considerations.  
2.7.1 Pre operative management 
Once the diagnosis of obesity is made it is important to quantify the burden of the disease 
and search for associated diseases and complications.  On taking the history the patient 
should be asked questions pertaining to the duration of their weight problem. Has the 
patient received anaesthesia and if so any complications. A detailed systemic enquiry 
should be undertaken with special attention to the respiratory and cardiovascular 
systems. Respiratory enquiry should include symptoms of pulmonary hypertension, 
exertional dyspnoea, fatigue and syncope which show the inability to increase cardiac 
output during activity. A history of snoring or symptoms of OSAS should be elicited. This 
should include the STOP-BANG screening questionnaire. (Appendix 1). Enquiry of the 
cardiovascular system should include a history of hypertension and atherosclerosis. The 
functional status of the patient should be noted including ability to do daily activities of 
living. Diabetes should be enquired about and if present the degree of control. 
Gastointestinal symptoms should be enquired about including dyspepsia and reflux. 
Obese patients are at risk of deep vein thrombosis.Previous deep vein thombosis should 
be enquired about. (27, 32, 90) 
Medication the patient is on currently, including weight reduction medication should be 
noted. Amphetamine based appetite suppresants contribute to increased cardiac risk 
(32). 
Examination 
Height and weight of the patient should be done and the obesity graded. A note should 
also be made as to fat distribution, as abdominal obesity is associated with more 
morbidity. The patient should be examined in the supine position to assess ability to 
tolerate this position. Careful assessment of the airway is important. Patients often have 
short necks and parapharyngeal fat that makes intubation difficult. Mouth opening, 
Mallampati score and neck extension should be assessed. The patient should be 
evaluated for systemic hypertension, pulmomary hypertension, ischaemic heart disease 
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and signs of right and or left ventricular failure. Characteristic signs of cardiac failure, 
increased jugular venous pressure, added heart sounds, pulmonary crackles, 
hepatomegaly, and peripheral oedema may be difficult to illicit in obese patients. 
Peripheral and central venous access should be evaluated during the pre operative visit 
and the possibility of invasive monitoring discussed with the patient. (27, 32, 90) 
Investigations should be patient and procedure specific and goal directed and may 
include blood investigations. Full blood count may reveal a polycythemia. There may be 
renal dysfunction, an increased glomerular filtration rate and proteinuria is often found in 
obese patients, especially in the case of associated diabetes and hypertension. Liver 
function tests may be appropriate if the patient is suspected of having nonalcoholic 
steatohepatitis. Blood glucose should be done as obese patients often have diabetes or 
impaired glucose tolerance. Coagulation studies should be done before surgery. Patients 
often have chronic vitamin K deficiency which can lead to an abnormal prothrombin time 
with a normal partial thromboplastin time because of deficiency of clotting factors II, VII, 
IX, and X. An arterial blood gas may be needed, especially if the patient is suspected of 
having obesity hypoventilation syndrome (Pickwickian) or OSAS. A baseline arterial blood 
gas will help evaluate carbon dioxide retention and provide guidelines for peri-operative 
oxygen administration and help decide on the need for post operative ventilation. A sleep 
study, where available, may be useful to diagnose OSAS. An ECG should be done in 
hypertensive patients or morbidly obese patients as they commonly have right ventricular 
hypertrophy, as evidenced by tall precordial R waves, right axis deviation and right 
ventricular strain.  Echocardiogaphy may be needed to assess systolic and diastolic 
function, but this may be technically difficult due to poor cardiac windows. Tricuspid 
regurgitation may be useful to confirm the presence of pulmonary hypertension. A chest 
X-ray is helpful to detect cardiomegaly or evidence of heart failure as well as underlying 
lung pathology and prominent pulmonary arteries, suggestive of pulmonary 
hypertension. Cardiorespiratory testing would be beneficial in these patients to test 
reserve. Premedication for these patients is a problem as they may further depress 
respiratory function. Prophylaxis against aspiration and deep vein thrombosis should be 
given. Risk of deep vein thrombosis should be discussed with the patient pre operatively. 
Pharmacologic intervention with a H2- receptor antagonist (e.g. cimetidine, ranitidine), 
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nonparticulate antacids (e.g. sodium bicarbonate) and proton pump inhibitors (e.g. 
omeprazole) reduce gastic volume and acidity, reducing the risk of aspiration. (27, 32, 90) 
2.7.2 Intra operative management 
Airway management 
In the American Society of Anesthesiologists Closed Claim Database (91) obese patients 
were involved in 37% of all adverse airway events occurring upon induction and 58% of 
those following extubation. Increased BMI is an independent predictor of difficult mask 
ventilation and rapid desaturation (92). Another important predictor is a history of 
snoring or OSAS. There is also a reported three times more difficult intubation rate in the 
obese as compared to lean patients (93). High Mallampati score, increased neck 
circumference, and excessive pretracheal adipose tissue have been shown to increase the 
risk of difficult laryngoscopy in obese patients (94). 
 
Various anatomical factors contribute to difficult airway management in obese patients. 
Excess adipose tissue in the face and cheeks makes applying a tight fitting mask 
challenging. Large breasts in both sexes encroach on the submandibular area making 
external laryngeal manipulation difficult and restricting access for laryngoscope handles 
and other intubation devices. Increased deposition of adipose tissues in the anterior neck 
further restricts access and makes palpation of landmarks for emergency surgical airway 
access difficult. Fat deposition in the posterior aspect of the neck and occiput, when 
severe, can reduce craniocervical mobility, interfering with head positioning and mouth 
opening for optimal intubation conditions. Parapharyngeal fat deposition, besides being a 
strong association of OSAS, causes narrowing of the airway making laryngoscopy difficult. 
Difficult airways are associated with death, brain injury, cardiopulmonary arrest, 
unnecessary tracheostomy, airway trauma, and damage to teeth.  In preparation for 
instrumentation of the airway of an obese individual, proper positioning must be in place. 
This includes placing a blanket or wedge under the shoulders to compensate for the 
exaggerated flexed position from the posterior cervical fat. The tip of the chin is placed 
higher than the chest facilitating laryngoscopy and intubation. (91) 
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Obesity may in some way promote the development of gastro-oesophageal reflux disease 
and patients may need to be treated as an aspiration risk but obesity alone is not a risk 
factor for pulmonary aspiration.(32) 
Obese patients should be well preoxygenated, preferably for a full three minutes or 
longer, with a well sealed mask, as these patients have up to a 50% decrease in FRC upon 
induction of anaesthesia. The decreased oxygen reserve combined with a higher 
metabolic rate in obesity means that these patients desaturate quicker. Intubation 
strategies should include a well thought out plan of what equipment would best suit the 
patient, and readily available back up devices which the user is proficient with should the 
initial intubation strategy not work. An awake intubation may be a preferred option. The 
American Society of Anesthesiologists difficult airway algorithm should be kept in mind 
for these patients. (91) 
 
Positioning 
Specially designed tables may be required for safe anaesthesia in obese patients. The 
weight limit of the operating table should be checked. Electrically operated tables may 
facilitate moving and positioning of patients. Care should be paid to protecting pressure 
areas as pressure ulcers and neural injuries are common especially in the morbidly obese 
and diabetic patients. Brachial plexus and sciatic nerve injuries are common. Stretch 
injuries may be caused by extreme abduction of the arms stretching the lower roots of 
the brachial plexus. (27) 
Monitoring 
Standard monitoring, as applicable to all patients, should be used including oxygen 
saturation monitoring, electrocardiogram recordings, and blood pressure monitoring. In 
morbidly obese individuals it may be difficult to obtain an accurate blood pressure via non 
invasive means as the patients may have conical upper arms that provide a poor fit for 
the non invasive cuff. Appropriately sized cuffs may be unavailable and cuffs too small for 
the individual can give a falsely high blood pressure reading. Cuffs with bladders that 
encircle at least 75% of the upper arm or preferably the entire arm should be used. 
Comparable and accurate blood pressure readings can be obtained from the wrist or 
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ankle using appropriately sized cuffs. In cases where no accurate non invasive blood 
pressure can be obtained an invasive blood pressure may need to be obtained via 
insertion of an arterial line. This has the added benefit of allowing sampling of blood for 
arterial blood gases. (27) 
Ventilation strategies 
A change of position from upright to supine causes a decrease in lung volume and 
respiratory system compliance in all patients, but these effects are magnified in the 
obese. In obese patients functional residual capacity is reduced and there is an associated 
decrease in lung and chest wall compliance. In anaesthetised obese patients, functional 
residual capacity decreases to approximately 50% of the pre induction value. (27) This is 
accompanied by atelectasis developing in the dependent regions of the lung, which may 
persist for 24 hours or longer post operatively, contributing to a reduction in the 
respiratory system compliance. The exaggerated atelectasis in obese individuals leads to 
an increased intra-pulmonary shunt and decreased partial pressure of arterial oxygen. 
To prevent resorption atelectasis and hypoxaemia during apnoea at induction, it is 
recommended that continuous positive airway pressure is used to pre oxygenate the 
patient and the fraction of inspired oxygen concentration is limited to less than 80%. To 
expand atelectasis, recruitment manoeuvers are suggested. This entails maintaining 
sustained airway pressure for 8 to 10 seconds at greater than or equal to 40 cm water. It 
is important to monitor the patient for hypotension and bradycardia during these 
manoeuvers. These may be repeated intermittently to prevent reoccurrence of 
atelectasis. The effects of recruitment should be monitored by means of monitoring PaO2 
to confirm improvement of gas exchange. The improvement of lung compliance should 
also be monitored to ensure a balance between optimal gas exchange and preventing 
lung over distension. The lungs can be kept recruited by using positive end expiratory 
pressure of between 10 to 12cm of water. Positive end expiratory pressure should be 
used in conjunction with monitoring for hypotension and decreasing arterial oxygenation, 
as PEEP may increase pulmonary shunting. It is important not to increase ventilatory 
airway pressure excessively as it may lead to parenchymal stress, causing ventilatory 
associated lung injury. To avoid  lung overdistension  tidal volumes of 6 to 10 ml per 
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kilogram of ideal body weight should be used, end inspiratory pressures should be kept 
below 30 cm of water, the rate can be increased, and permissive hypercapnia can be used 
if necessary. (27, 32) 
Obesity and anaesthetic agents 
Pharmacokinetics is altered. Obesity brings about changes which affect the metabolism of 
drugs and therefore the dosing of these drugs (25). Blood volume increases 
proportionately to body weight leading to an increased cardiac output. Obese patients 
have increased lean body weight compared to normal. Even though obese patients have 
increased fat mass the adipose tissue is significantly less perfused, so lipophilic substances 
do not have a bigger volume of distribution. Obese patients have increased extra-cellular 
fluid thus increasing the volume of distribution of hydrophilic substances. Nonalcoholic 
steatohepatitis with or without liver dysfunction is common but no studies have looked at 
its effect on drug clearance. Dosing recommendations are usually based on total body 
weight. This approach is valid for normal weight subjects, total body weight and ideal 
body weight are similar. In morbidly obese patients the fat mass accounts for an 
increasing proportion of total body weight with a decreased lean body weight to total 
body weight ratio. Drug administration based on total body weight can result in overdose 
and drugs based on ideal body weight can lead to underdosing. (24-26)  
Hypnotics 
Thiopental is rapidly distributed from the plasma into the peripheral tissues. Termination 
of effect is due to rapid distribution in peripheral tissues (26). High lipophilicity increases 
the drug volume of distribution and elimination half-life in obese individuals. Total 
clearance is increased two fold in obese individuals but when normalised to total body 
weight there was no significant difference in clearance. Obese patients have a higher 
cardiac output compared to normal weight individuals and cardiac output is an important 
determinant of distribution with intravenous drugs. Thiopental induction doses adjusted 
to lean body weight resulted in the same peak plasma concentrations as doses adjusted 
to cardiac output. Induction should be based on lean body weight and maintenance on 
total body weight as volumes and clearance increase proportionally with total body 
weight. (24, 26) 
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Propofol distribution is similar to that of thiopental distribution. It is lipophilic, and 
distributes rapidly from plasma into peripheral tissues, which accounts for its short 
duration of action. Cardiac output is a determinant of peak plasma concentration. 
Comparison with non obese patients shows that the systemic clearance and the volume 
of distribution at steady state were related to total body weight. The elimination half life 
was found to be similar between obese and non obese individuals. It is recommended 
that propofol be dosed according to lean body weight, and maintenance should be based 
on total body weight. (24, 26, 95) 
There is limited data as to the pharmacokinetics of etomidate, but based on its similarity 
to propofol it is recommended that it be dosed according to lean body weight. (26) 
Opioids 
Fentanyl has a high lipid solubility. Studies of pharmacokinetics in obese and normal 
weight patients have shown that the higher cardiac output in obese patients results in 
significantly lower fentanyl concentrations in the early phase of distribution. Clearance is 
also higher in obese patients. Recommendations have been made to dose fentanyl 
according to lean body weight as clearance increases arbitrarily with pharmacokinetic 
mass (a derived hypothetic scalar) which correlates well with lean body weight. 
Remifentanil similarly should be dosed on lean body weight. Obesity increases the risk of 
peri-operative hypoxia and as such all opioids should be carefully titrated according to the 
individual patients needs. (24, 25, 27) 
Inhalational agents 
Isoflurane is more lipophilic than desflurane or sevoflurane. Obese and non obese 
patients responded to commands equally after 0.6 minimum alveolar concentration of 
isoflurane in procedures lasting 2 to 4 hours. This may be due to the fact that even 
though the obese patients have increased body fat and an increased cardiac output, the 
blood flow per kilogram of body fat decreases with increasing obesity. Sevoflurane 
appears to have a slighty more rapid uptake and elimination than isoflurane (26). In 
general the effect of BMI on desflurane uptake is insignificant (25). 
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Neromuscular blocking drugs 
These are dosed on ideal body weight, except succinylcholine which is dosed according to 
total body weight as the amount of extracellular fluid and pseudocholinesterase is 
increased. The polar hydrophilic nature of nondepolarising neuromuscular blockers limits 
their volume of distribution. A more predictable clinical effect occurs when based on ideal 
body weight. (24, 28) 
Other considerations 
Regional anaesthesia is an anaesthetic technique which would be beneficial to obese 
patients as it would allow pain control and is opioid sparing. The respiratory benefits 
include no manipulation of the airway, less post operative reduction in vital capacity and 
quicker return to pre operative lung volumes. Regional procedures in these patients 
however are technically difficult. (32) 
Obese patients are at high risk of post operative wound infections and as such should 
receive antibiotic prophylaxis. (27) 
Thromboprophylaxis is necessary as morbid obesity is an independent risk factor for 
acute post operative pulmonary embolus causing sudden death. Thromboprophylaxis 
should be administered until the patient is fully mobile. (27) 
2.7.3 Post operative management 
Monitoring of the obese patient 
In general, no special monitoring is needed for the obese patient undergoing short and 
uncomplicated surgery. The length and complexity of surgery as well as the baseline 
functional status of the patient pre operatively dictate special monitoring. Obese patients 
who have undergone upper abdominal surgery are at increased risk of post operative 
atelectasis. A strategy for minimising this could include initiation of continuous positive 
pressure in recovery room and continuing overnight. Post operatively these patients 
should be kept in the recovery room longer than non obese patients especially when they 
have a history of OSAS. They should also be monitored closely for desaturation. A lower 
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threshold for admitting these patients to high care facilities or intensive care units should 
exist. (27, 28) 
Analgesia should be carefully titrated and monitored. Post laparotomy pain may cause 
patients to avoid taking deep breaths, worsening atelectasis. Adequate analgesia and 
abdominal support may encourage patients to co-operate with early ambulation and 
incentive spirometry. (27) 
Thromboprophylaxis should be given until the patient is ambulating as patients are at 
increased risk of thrombotic disease. (27) 
2.8 Definition of OSAS  
OSAS is a chronic condition where the patient frequently stops breathing during sleep, 
due to repetitive complete or partial collapse of the upper airway causing obstruction 
(96). 
2.9 Prevalence of OSAS 
The prevalence of OSAS is on the rise, especially in the face of increasing obesity. The 
prevalence of OSAS is under reported as only a small proportion of the population is 
adequately screened (5). The prevalence ranges from 9 to 26% depending on the study 
population and how the studies were conducted. (3, 4) A problem with describing the 
prevalence is that different studies use different methods to describe whether or not a 
patient meets the criteria for OSAS. Some studies use the apnoea hypopnoea index (AHI), 
whilst others use screening questionnaires.  
The prevalence of OSAS in the surgical population is shown to be higher than that in the 
general population. This varies with the different surgical populations with patients for 
bariatric surgery having pervalences of as high as 95% (3, 20, 97). 
Young et al (5) showed the estimated prevalence of OSAS in the adult USA population is 
20%, then Hiestand (3) demonstrated  that 25% of the adult population in the USA were 
at risk of OSAS. Finkel et al (4) screened adult surgical patients for OSAS at an academic 
hospital, using the apnoea risk evaluation system (ARES) OSAS screening questionnaire. 
This questionnaire combined three different screening tools, the Berlin questinnaire, the 
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Epworth sleepiness scale and the Flemons index. The patients who screened high risk 
were then offered a home sleep study to determine if they had OSAS. Patients were then 
offered polysomnography to confirm the diagnosis. This study showed that  661 patients 
(23.7%) screened high risk for OSAS. Of these, 534 (81%) had no prior diagnosis of OSAS. 
Portable sleep studies were then done in 207 high risk patients, with no prior diagnosis of 
OSAS and 170 (82%) were detected to have OSAS. PSG’s were then done in 26 patients 
and OSAS was then confirmed in 19 patients. This study shows that undiagnosed OSAS is 
prevalent in adult surgical patients and it is important to screen for it.  
2.10 Pathophysiology of OSAS 
Obstructive sleep apnoea results from the forces that maintain a patent airway being 
overcome by forces that cause the airway to collapse. In individuals with OSAS, increased 
parapharyngeal soft tissue is found. This leads to a change in the geometry of the pharynx 
which reduces the effectiveness of the upper airway muscle tension and contraction that 
maintain patency of the upper airway.  Decreased lung volumes, especially in patients 
with central obesity, lead to decreased traction on the trachea, further increasing upper 
airway collapsibility and resistance. The nasopharynx, hypopharynx and oropharynx are 
not supported by bone or cartilage making them prone to collapse. The patency of these 
segments are thus determined by the activity and contraction of the pharyngeal dilator 
muscles.   
In patients with OSAS, rapid eye movement (REM) sleep results in decrease in the the 
upper airway neuromuscular activity and pharyngeal tone, leading to airway obstruction. 
The synchronisation of the upper airway and respiratory muscle activation prior to 
inspiration is disrupted in OSAS patients. The genioglossus muscle, responsible for 
preventing the tongue from falling back, especially in REM sleep, is relaxed in OSAS 
patients. Upper airway resistance increases during REM sleep as most of the pharyngeal 
dilator muscles relax. Diaphragmatic contraction produces sub-atmospheric pharyngeal 
pressure, leading to upper airway collapse involving the lateral pharyngeal walls. (5, 19)  
Increasing hypopnoeic and or apnoeic events lead to increasing hypoxaemia and 
hypercapnia which lead to increasing ventilatory effort that eventually terminates in 
arousal and return of the pharyngeal dilator activity. Repetitive sympathetic nervous 
34 
 
system activity triggers a series of events leading to cardiovascular and metabolic 
complications. During an apnoeic attack, bradycardia, sinus pauses, ventricular 
dysrhythmias and second degree heart block occurs in 50% of OSAS patients. These 
changes increase in frequency when the arterial oxygen saturation is less than 60%. The 
intermittent nocturnal sympathetic activation with systemic hypertension and recurrent 
hypoxic pulmonary vasoconstriction with pulmonary hypertension may provide an 
explanation of right and left ventricular hypertrophy in OSAS patients. These 
cardiovascular changes increase the myocardial infarction and stroke rate in the OSAS 
population with associated increased mortality in patients that are untreated.  
There is evidence that the hormone leptin is implicated in OSAS as it impairs the response 
to apnoea related hypercapnia and interferes with the arousal response. Oxidative stress 
secondary to hypoxia and reperfusion and high levels of cytokine contribute to 
endothelial dysfunction. There are complex changes that come into play in addition to the 
sympathetic activation which is responsible for the atherosclerotic cardiovascular disease 
and metabolic changes. Co-morbidities associated with OSAS include arterial 
hypertension, coronary artery disease, cerebrovascular disease and stroke, congestive 
cardiac failure, cardiac dysrhythmias, and diabetes mellitus. OSAS is an independent risk 
factor for the development of the metabolic syndrome. (27-29) 
2.11 Risk factors of OSAS 
Male gender is a predisposing factor. The exact etiology of this is unclear. Age greater 
than 40 is associated with greater pharyngeal collapsibility during sleep and therefore the 
risk of OSAS increases with age. A BMI greater than 35 kg/m2 is associated with OSAS. The 
distribution of adipose tissue is significant with abdominal fat distribution or visceral fat, 
an increased waist hip ratio, and a neck circumference of greater than 39 cm in women 
and 41 cm in men being associated with an increased risk of OSAS. (19, 27, 98) 
2.12 Screening tests for OSAS and diagnosis of OSAS 
OSAS is associated with peri-operative morbidity but is under diagnosed. A 2012 study 
carried out by Singh et al (99), in Canada, investigated patients attending a pre operative 
clinic over a 4 year period. Of the 819 patients in their sample 111 had pre-existing OSAS. 
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Of the patients that were screened using the STOP-BANG questionnaire, 708 then had 
polysomnography (PSG) studies.  The study found that 233 (31%) of the patients had no 
OSAS. The OSAS was then classified in terms of severity using the Apnoea Hyponoea Index 
(AHI). 218 (31%) had mild OSAS (AHI: 5 to 15), 148 (21%) had moderate OSAS (AHI: 15 to 
30), and 119 (17%) had severe OSAS (AHI: >30). Of the 267 patients with moderate to 
severe  OSAS 92% (n = 245) was not diagnosed by the surgeons and 60% (n = 159) of the 
patients were not diagnosed by the anaestheists. This study concluded that both 
anaesthetists and surgeons failed to identify the majority of patients with pre-existing 
OSAS  and symptomatic undiagnosed OSAS before operation. This highlights the need for 
vigilence when screening pre operative patients. Many tools are available for screening 
OSAS. They are mainly based on questionnaires and are thus subjective. These 
questionnaires are then usually vailidated against the gold standard screening for OSAS, 
polysomnography.  
The Berlin questionnaire 
The Berlin questionnaire (Figure 2.1) was among the first sleep apnoea screening tools 
designed specifically for use in primary care settings. The questionnaire was the outcome 
of a consensus conference in Berlin, Germany, in April 1996. As part of the conference, 
120 German and American primary care and pulmonary physicians chose questions from 
the literature relating to the risk of developing sleep apnoea. The result was a 14 item 
screening tool designed to assess the presence of sleep apnoea symptoms such as 
snoring, daytime sleepiness, and drowsiness when driving. This information was then 
correlated with patient specific data on age, gender, ethnicity, height, weight, neck 
circumference, and blood pressure. The Berlin questionnaire was initially used and 
validated for outpatient screening of OSA in primary care clinics but has also been 
validated as a screening tool in the surgical population. (22, 31, 100) 
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    Figure 2.1 Berlin questionnaire (100) 
 
American Society of Anesthesiologists OSAS scoring 
The  American Society of Anesthesiologists practice guidelines offer a scoring system 
(Table 2.4) that can be useful to estimate whether a patient is at increased peri-operative 
risk of complications from OSA. This includes questions about type of surgery and 
anaesthesia, use of post operative anaesthesia and presence and severity of OSAS or 
suggestive symptoms. This score consists of 3 sections .The overall point score for section 
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A is added to the score for either section B or C depending on which is greater to give a 
score from 0 to 6. Patients with a score of 4 are at increased peri-operative risk from OSA. 
Patients with a score of 5 or 6 are at significantly increased peri-operative risk from OSA. 
(29)   
Table 2.4 American Society of Anesthesiologists (ASA) Scoring system for Peri-operative 
risk from OSA (29) 
ASA Scoring system for Peri-operative risk from OSA Points 
A- Severity of sleep apnea based on sleep study (or clinical 
indicators if sleep study not available). Point score (0-3) 
Severity of OSA 
None 
Mild 
Moderate 
Severe 
 
 
 
0 
1 
2 
3 
B-Invasiveness of surgery and anesthesia. Point score (0-3) 
Type of surgery and anesthesia 
Superficial surgery under local or peripheral nerve block anesthesia 
without sedation 
Superficial surgery with moderate sedation or general anesthesia 
Peripheral surgery spinal or epidural anesthesia 
Peripheral surgery with general anesthesia 
Airway surgery with moderate sedation 
Major surgery, general anesthesia 
Airway surgery, general anesthesia 
 
 
 
0 
1 
1 
2 
2 
3 
3 
C-Requirements for post operative opioids. Point score (0-3) 
Opioid replacement 
None 
Low dose oral opioids 
High-dose oral opiods, parenteral or neuraxial opioids 
 
 
0 
1 
3 
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STOP-BANG questionnaire 
The STOP-BANG questionnaire (23) as illustrated in (Table 2.5) was developed by Chung in 
2008 in Toronto, Canada. It was validated using sleep studies. The STOP-BANG 
questionnaire consists of eight yes/no questions. The origin of this acronym can be seen 
in table 2.5 (STOP-BANG, Snoring, Tiredness, Observed apnoea, Pressure, BMI, Age, Neck 
cicumference, Gender). A score of 1 is given to a yes response and 0 for a no response. 
The score ranges from 0 to 8. A score greater than or equal to 3 has a 93% specificity and 
100% sensitivity for predicting the probability of OSAS in moderate and severe cases 
respectively. Its simplicity and ease of administration as well as validation in the surgical 
population make it a useful screening tool, especially in an environment where there are 
communication, time and budget constraints that do not afford us the luxury of 
complicated questionnaires or expensive sleep studies. (23) 
Table 2.5 STOP-BANG Questionairre (23) 
 STOP-BANG Sleep Apnea Screening Tool YES NO 
1. Do you SNORE loudly (louder than talking or loud enough to be 
heard through closed doors)? 
  
2. Do you often feel TIRED, fatigued, or sleepy during daytime?   
3.  Has anyone OBSERVED you stop breathing during your sleep?   
4. Do you have or are you being treated for high blood PRESSURE?   
5. BMI more than 35?   
6. AGE over 50 years old?   
7. NECK circumference > 15.75 inches? (39.375cm)   
8. Male GENDER?   
 
Epworth sleep scale 
The Epworth Sleepiness Scale (Figure 2.2) was created by Murray Johns at the Epworth 
Sleep Centre in Australia. It is a simple, self administered questionnaire which provides a 
measurement of the general level of daytime sleepiness. The individual is asked on a scale 
of 0 to 3 to score the likelihood of falling asleep in eight different situations. Although it 
has the advantage of being brief and simple, the score is subjective and may convey 
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symptoms of fatigue rather than purely excessive daytime sleepiness. Arbitrarily, a score 
of >10 has been suggested as being an indicator of ESS, but on an individual basis, the ESS 
cannot be used as a diagnostic tool for OSAS in isolation. Detailed history and 
polysomnography is recommended. Whether an ESS score can predict health outcomes is 
not clear, but it is popular due to its simplicity. (101) 
  
Figure 2.2 Epworth Sleepiness Scale (101) 
Polysomnography 
Polysomnography is the gold standard for diagnosis and assessment of severity of OSAS. 
Sleep is divided into rapid eye movement (REM) sleep and non-rapid eye movement 
(NREM) sleep. It begins with NREM, during which period the electroencephalogram 
shows slowing down of brain waves. When approximately two hours of sleep has 
completed, brain activity increases and REM sleep begins. There are between 4 to 6 sleep 
cycles a night, with the REM portion of sleep lengthening with each cycle.  
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Polysomnography is able to monitor the stages of sleep as well as the  sleep cycles and 
can then determine when sleep patterns are disrupted and possible reasons for these 
disruptions. Polysomnography is non-invasive, painless and carries few complications. 
Patients prepare for the test by omitting alcohol and caffeine from their diets in the 24 
hours prior to polysomnography. It requires an overnight stay at a sleep laboratory where 
numerous complex recordings are taken. These include electroencephalogram, 
electrooculogram, submental electromyogram, electrocardiogram, ribcage and 
abdominal excursion, oro-nasal airflow measurements, oxyhaemoglobin saturation and 
non-invasive blood pressure monitoring. The results are then analysed and summarised 
using indices for OSAS severity.  
The apnea hypopnea index (AHI) is a popular index used which is an indication of the 
number of apnoeas per hour of total sleep time and the number of hypopnoeas per hour 
of total sleep time. The American Society of Anesthesiologists regards an AHI of 0 to 5 as 
normal, 6 to 20 is suggestive of mild OSAS, 21 to 40 moderate OSAS, and greater than 40 
as severe OSAS. (Table 2.6) While PSG is the gold standard, it is costly and time 
consuming, limiting its use. (27, 29, 36, 96, 102) 
Table 2.6 Severity of OSA (29) 
Severity of OSA AHI 
None 0-5 
Mild OSA 6-20 
Moderate OSA 21-40 
Severe OSA >40 
2.13 Anaesthetic management of OSAS 
The peri-operative management of patients is critical in patients with OSAS. OSAS 
predisposes patients to a greater than normal risk of peri-operative complications. (31, 
33, 103) Patients who are undiagnosed as having OSAS pose the biggest threat as they are 
sub-optimally prepared and thus at increased risk of adverse events. (31) Attention to 
detail and careful preparation ensuring a safe anaesthetic is imperative. Peri-operative 
complications associated with OSAS are numerous. These range from  higher rates of 
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reintubation, oxygen desaturations, cardiac arrhythmias, myocardial injury, delirium, 
unplanned ICU transfers and longer hospital stays to nearly fatal respiratory 
complications and even unexpected deaths which have been reported post operatively, 
especially in patients with OSAS that was unrecognised or inadequately treated peri-
operatively. (4, 104) 
Pre operative evaluation 
The pre operative assessment starts by having a high index of suspicion in patients who 
are obese and have a body habitus suggestive of OSAS. This includes BMI of 35 kg/m2, 
neck circumference greater than 39 cm, craniofacial abnormalities affecting the airway, 
anatomical nasal obstruction and tonsils nearly touching in the midline. Pre operative 
questionnaires like the STOP BANG questionairre can be used to screen patients at risk 
and assess the need for further testing. Polysomnography is expensive and not easily 
available. Confirmed diagnosis pre operatively is unlikely, a presumptive diagnosis thus 
needs to be made. Pre operative initiation of CPAP should be considered especially in 
cases of severe OSAS. Once suspicion has been raised, a baseline function is needed. The 
grading of the severity of OSAS is important . Associated complications of OSAS need to 
be screened for, including hypoxaemia, arrhythmias, myocardial infarction and apnoeas. 
(31, 33) Associated co-morbidities need to be screened for, including, diabetes, and 
hypertension. All of which make the peri-operative management  more complicated. (4) 
Physical examination pre operatively should pay particular attention to the evaluation of 
the airway, nasopharyngeal space, neck circumference, tonsil size and tongue volume 
(98). The patient and their family as well as the attending surgeon should be informed of 
the suspicion of OSAS as well as the associated peri-operative risks. (29) 
The decision to perform day case surgery should be carefully considered with the risks 
and benefits taken into consideration. Factors to be taken into consideration are type of 
surgery, for example lithotripsy, minor orthopaedic surgery and superficial surgery which 
may be suitable for day case procedures. The type of anaesthesia given should also be 
taken into consideration, with local or regional anaesthesia considered safer for 
outpatient surgery than general anaesthesia. The patients functional status and co-
morbidities also need to be taken into consideration as a patient who is at high risk of 
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morbidity may not be suitable for day case procedures for even the most minor of 
surgical procedures. (29) 
Patients on CPAP should be encouraged to continue using their CPAP and to bring in their 
machines to be used pre operatively and post operatively as it has been found to 
decrease the number of post operative adverse events. The pre operative use of 
mandibular advancement devices or oral appliances should also be encouraged as should 
pre operative weight loss. (29) 
Premedication is usually omitted in these patients. Sedative, analgesic and anaesthetic 
agents used peri-operatively play a major role in the development of sleep disordered 
breathing during the post operative period. (33) 
Intra operative management 
Difficulties are often encountered with airway management. (31) Intra operatively 
patients with OSAS have a higher risk for morbidity and mortality due to potential 
difficulty in maintaining a patent airway. (33) They should have a well thought out plan 
for their analgesia. Opioid sparing strategies should be employed where possible. Use of 
non steroidal anti inflammatory drugs and multimodal analgesia should also be 
employed. The use of regional anaesthesia when possible should be considered. The 
American Society of Anesthesiologists task force on peri-operative management of 
patients with OSAS agreed that the use of local anaesthesia or peripheral nerve blocks 
rather than general anaesthesia improves outcomes in patients undergoing peripheral 
surgery. Controversy surrounds whether or not opioids should be used in epidurals. (28, 
29) 
Effects of sedatives, analgesics and anaesthetic agents play an important role in upper 
airway dynamics. Anaesthetic and sedative drugs are central nervous system depressants, 
which inhibit respiration. Sedation and anaesthesia, similar to the changes that occur in 
sleep, reduce functional residual capacity and predispose to atelectasis. (33) In 
comparison with normal individuals patients with OSAS seem to be more sensitive to the 
effects of sedation and anaesthesia (31). Phasic pharyngeal muscle contraction is 
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markedly reduced by REM sleep and the administration of narcotic analgesia predisposing 
to airway collapse (33). 
Patients with increased peri-operative risk from OSAS should be extubated only when 
fully awake and reversal of neuromuscular blockade has been confirmed. Patients should 
also be placed in a semi upright position for extubation and recovery. The American 
Society of Anesthesiologists task force also agree that general anaesthesia with a secured 
airway is preferable to deep sedation for superficial procedures especially when 
procedures involve the upper airway. (29) 
All the considerations with obese patients must also be taken into account including 
positioning and protection of pressure points. (27) 
Post operative management 
Post operatively a high care bed must be secured. OSAS patients are prone to respiratory 
depression and desaturation post operatively due to the sedative effects of anaesthetic 
agents combined with analgesic agents which are respiratory depressants. This 
necessitates the need for monitoring in the post operative period. Continuous oximetry 
reduces the risk of peri-operative complications. Supplemental oxygen should be 
administered to keep levels at baseline oxygenation and discontinued when they can 
maintain baseline oxygenation on room air. If frequent or severe airway obstruction or 
hypoxaemia occurs during post operative monitoring, initiation of CPAP should be 
considered.  Supplemental oxygen may increase the duration of apnoeic episodes and 
may hinder detection of atelectasis, transient apnoea and hypoventilation by pulse 
oximetry. The supine position should be avoided when possible during recovery.  The 
type and extent of surgery has significant impact on disturbances of sleep architecture in 
the post operative period. (30, 31, 33, 104) 
Analgesia post operatively should be carefully monitored, as reduced doses of opioids 
need to be used as regular doses may render the patient apnoeic. (27) 
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2.14 Conclusion  
In this chapter the literature pertaining to obesity and OSAS was discussed. The 
definitions, prevalence, pathophysiology, risk factors, diagnosis, sequelae, and 
anaesthetic considerations of obesity and OSAS were delved into. 
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Chapter Three:  Research methodolgy 
3.1 Introduction 
This chapter will discuss the problem statement, aims and objectives, ethical 
considerations, research methodology and the validity and reliability of this study.  
3.2 Problem statement  
Obesity is associated with increased co-morbid conditions and increased morbidity and 
mortality among patients undergoing surgery (34). OSAS is associated with further 
perioperative morbidity and mortality (29), and is under diagnosed in a large number of 
patients (3, 5, 20). Finkel et al (4) in 2009 described an 82% prevalence of undiagnosed 
OSAS among American adults presenting for surgery.  Obesity and OSAS have implications 
for the anaesthetic management of patients (25, 28, 30, 35, 36). It is therefore important 
for the anaesthetist to know the occurrence of obesity and OSAS in the patient 
population presenting for surgery. 
The occurence of obesity and the risk of OSAS among patients at Chris Hani Baragwanath 
Academic Hospital (CHBAH) who present for elective surgery is unknown.  
 3.3 Aim and objectives  
3.3.1 Aim 
The aim of this study was to describe the occurrence of obesity and risk of OSAS in adult 
patients going for elective surgery at the J.D. Allen and the Gynaecology Theatre Complex, 
at CHBAH. 
3.3.2 Objectives 
The primary objectives of this study were to: 
 describe the BMI of adult patients undergoing elective surgery   
 describe the risk of OSAS using the STOP-BANG questionnaire.   
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The secondary objectives of this study were to: 
 compare the  BMI with risk of OSAS 
 compare the BMI with gender 
 compare the BMI with age 
 compare the risk of OSAS with gender  
 compare the risk of OSAS with age.   
3.4 Ethical considerations 
 The  study was approved by the Human Research Ethics Committee (Medical) (Appendix 
4) and the Post Graduate Committee of the University of Witwatersrand (Appendix 5).  
Written consent to undertake the study was sought from the Medical Advisory Commitee 
of CHBAH (Appendix 6). The operating theatre nursing managers were informed of the 
study. 
Adult patients presenting for elective surgery were invited to take part in the study. The 
researcher explained the study to the patients and those agreeing to participate received 
an information letter (Appendix 2) and were asked to sign informed consent (Appendix 3). 
The patient information letter detailed the nature of data collection and reasons for the 
study. 
When patients were concerned about their weight, they were informed of the dietetics 
department at CHBAH, who run a weight management programme, so that their problem 
could be further addressed. No patients were followed up as to their participation in the 
weight management programme. 
The data collection was anonymously done as each patient was allocated a study number. 
A list with the study numbers and the patients’ names were kept in a seperate file and 
only the study numbers were used on the data collection sheets. Confidentiality was 
ensured as only the reasearcher and supervisor had access to the data. The data will be 
stored securely for six years after completion of the study. 
This study was carried out in accordance with The Declaration of Helsinki (39) and the 
South African Good Practice Guidelines  (40). 
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3.5 Research methodology  
3.5.1 Research design 
A prospective, contextual, descriptive study design was utilised.The study was prospective 
as it measured variables that occurred during the course of the study. In prospective 
studies data is first collected and then outcome is measured (105). The study was 
contextual as it took place only in a specific location (105), in this case CHBAH. A 
descriptive design aims to describe a situation or identify problems through observation, 
description or classification without manipulating variables. (105)  This study described 
the occurrence of obesity and risk of OSAS in adult patients going for elective surgery at 
the J.D. Allen and the Gynaecology Theatre Complex, at CHBAH. 
3.5.2 Study population 
 The study population was adult patients presenting to CHBAH for elective surgery in the 
disciplines of: 
 general surgery 
 orthopaedic surgery 
 plastic and reconstructive surgery  
 maxillo-facial surgery 
 urological surgery  
  gynaecological surgery 
 otorhinolaryngology and 
 neurosurgery. 
3.5.3 Study sample 
Sample size 
In consultation with a bio-statistician using nQuery Advisor, a sample size of 250 patients 
was needed to yield a sample size of approximately 100 obese patients assuming a 40% 
prevalence of obesity among this population. With a sample size of approximately 100 
obese patients, a two sided 95% confidence interval for the proportion of patients with 
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risk of OSAS using the large sample normal approximation will extend 0.1 from the 
observed proportion for an expected proportion of 0.5.  
Sampling method 
A convenience sampling method was used. Convenience sampling is referred to as 
“availability” sampling and it involves the choice of readily available participants or 
objects for the study (105). Patients presenting to CHBAH for elective surgery on the days 
that the reasearcher collected data were invited to partake as they were readily 
accessible. 
Inclusion and exclusion criteria 
Inclusion criteria for this study were: 
 adult patients 18 years and older  
 presenting for elective surgery 
 able to stand upright. 
Exclusion criteria for this study were: 
 patients declining to participate in the study 
 and those with any medical condition which increases extracellular fluid and thus 
weight, for example ascites, cardiac failure, and renal failure. 
3.5.4 Data collection 
The data was collected over a period of 16 days, 2 weeks of which were consecutive in 
September 2013 and the remaining 2 days a week later during the month of October 
2013. The patients were sourced from two operating theatre complexes. For logistical 
reasons data was collected from the patients presenting for gynaecological surgery in the 
late afternoon the day before their surgery, in their respective wards. Any patients, from 
other elective surgical lists, already in the ward on the evening before their surgery also 
had their data collected. Data was collected from all other patients on the morning of 
their surgery in a private space in the operating theatre reception. 
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Adult patients presenting for elective surgery were invited to take part in the study. The 
researcher explained the study to the patients and those agreeing to participate received 
an information letter (Appendix 2) and were asked to sign informed consent (Appendix 3).   
The following data was collected and recorded on the data capture sheet:   
 demographic data 
 weight 
 height 
 neck circumference 
 STOP-BANG questionnaire. 
The weights of patients were measured by the researcher using the same scale for all 
patients. This was a calibrated electronic Seca® scale obtained from the dietetics 
department at CHBAH. The scale was placed on a flat surface. Patients were weighed 
wearing a light weight theatre gown, to ensure weights closest to actual weight.  
The patient’s heights were measured by the reseacher using  the same tape measure and   
identical method in order to standardise the results. The patients were asked to stand 
against a wall. A ruler held at 90 degrees to the wall was used to mark off the height. The 
straight line distance was then measured perpendicular to the floor using the tape 
measure. To measure neck circumference, the tape measure was placed around the 
patients neck just below the thyroid cartilage by the researcher (106).  
The STOP-BANG questionnaire, consisting of eight questions with yes/no answers was 
completed by the researcher for each patient. Each yes answer is weighted one point. A 
score of equal to or greater than 3 confers a high risk of OSAS. An interpretor was not 
needed as all patients sampled were proficient in English. 
3.5.5 Data analysis 
 All data recorded was captured on a Microsoft Excel spread sheet. The data was analysed 
in consultation with a bio-statistician using Stata version 13. Descriptive and inferencial 
statistics were used. Catergorical variables were summarised using frequencies and  
percentages. Continuous variables were summarised using means and standard 
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deviations and medians and interquartile ranges depending on the distribution of the 
data.  
3.6 Validity and reliability of the study 
Botma et al (107) defined the validity of a study as “the degree to which a measurement  
represents a true value” and the reliability of the study as “the consistency of the 
measure achieved”. This study was valid and reliable in that: 
 an appropriate study design was used 
 sample size was calculated in consultation with a bio-statistician 
 the researcher collected all the data from patients  
 the same equipment was used for all the patients 
 standardised methods of measuring weight, height and neck circumference were 
used (76, 106) 
  the BMI was measured using the internationally accepted formula (37) 
 The STOP-BANG questionnaire which is a validated screening tool was used to 
assess the risk of OSAS in patients (23) 
 data analysis was done in consultation with a bio-statistician. 
3.7 Summary 
In this chapter the problem statement, aims and objectives, ethical considerations, 
research methodology and the validity and reliability of this study were discussed. 
Discussion of the research methodology included the research design, study 
population, study sample, data collection and data analysis.  
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Chapter Four: Results and discussion 
4.1 Introduction 
This chapter presents the results of the study, as defined by the objectives, and  a 
discussion thereof.  
 The primary objectives of this study were to: 
 describe the BMI of adult patients undergoing elective surgery   
 describe the risk of OSAS using the STOP BANG questionnaire.   
 
The secondary objectives of this study were to: 
 compare the BMI with risk of OSAS 
 compare the BMI with gender 
 compare the BMI with age 
 compare the risk of OSAS with gender  
 compare the risk of OSAS with age. 
4.2 Attaining the study sample and approach to data analysis 
A total of 250 patients were needed for the study as determined by a bio-statistician.   
The data was collected over a period of 16 days, 2 weeks of which were consecutive in 
September 2013 and the remaining 2 days a week later during the month of October 
2013.  All 250  patients sampled were included in the study. Obesity was defined as a BMI 
≥ 30 kg/m2. A STOP-BANG score ≥ 3 conferred a risk of OSAS. 
4.3 Demographic Data 
Of the 250 patients in the study 153 (61.2%) were females and 97 (38.8%) males. There 
were 223 (89.9%) patients of black ethnicity. Other ethnic groups were, coloured 15 (6%), 
whites 10 (4%) and Indian 2 (0.8%).  When broken down into age groups ≥ or < 40, 52 
(53.6%) males and 112 (73.2%) females were ≥ 40 years old. Table 4.1 demonstrates this.  
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Table 4.1 Demographic data 
 Number Percentage 
Gender  
Male 97 38.8 % 
Female 153 61.2 % 
Ethnicity  
Black 223 89.2 % 
Coloured 15 6 % 
White 10 4 % 
Indian 2 0.8 % 
Age  
< 40 86 34.4 
≥ 40 164 65.6% 
4.4 Description of BMI 
The first primary objective was to  describe the BMI of adult patients  undergoing elective 
surgery. Of the sample, 81 (32.4%) patients had a BMI of ≥ 30 and were classified as 
obese. There were 69 (27.6%) obese females and  12 (4.8%) obese males in the study 
sample. The gender distribution by BMI classification for the sample is shown in Figure 
4.1. 
 
Figure 4.1 Gender distribution by BMI classification 
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4.5 Risk of OSAS 
The second primary objective was to describe the risk of OSAS using the STOP-BANG 
questionaire. A STOP-BANG score of < 3 was attained by 205 (82% ) patients and ≥ 3, 
indicating a risk for OSAS, in 45 (18%) patients. Of these 45 patients 22 (48.9%) had a BMI 
of < 30 and 23 (51.1%) had a BMI ≥ 30.  
4.6 BMI and the risk of OSAS 
The first secondary objective was to compare BMI with the risk of OSAS. A Chi-square test 
revealed statistically significant relationships between BMI and risk of OSAS, with lower 
risk being associated with a lower BMI (χ2 [1] = 8.77, p = 0.003). This is shown in Table 4.2. 
Table 4.2 Relationship between BMI and risk for OSAS 
 OSAS  
BMI At risk Not at risk Total 
≥ 30 23 58 81 
< 30 22 147 169 
Total 45 205 250 
 (p = 0.003) 
 
Of the 81 obese patients, 23 (28%) were at risk of OSAS and of the 169 non obese 
patients 22 (13.02%) were at risk of OSAS. 
4.7 BMI and gender 
The next secondary objective was to compare BMI with gender. A Chi-square test 
revealed a statistically significant relationship between BMI and gender in the sample 
with a lower BMI being associated with being male (χ2 [1] = 29.03, p = 0.001). This is 
shown in Table 4.3. 
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Table 4.3 Relationship between BMI and gender   
 Gender  
 BMI Male  Female Total 
≥ 30 12   69 81 
< 30 85 84 169 
Total 97 153 250 
 (p = 0.001) 
Of the 81 patients who were found to be obese 12 (14.81%) were male and 69 (85.18%) 
were female. 
4.8 BMI and age 
The third secondary objective was to compare BMI  and age. A Chi-square test revealed  a 
statistically significant relationship between BMI and age. Obesity was associated with 
age older than 40 years (χ2 [1] = 10.10, p = 0.001). This is shown in Table 4.4. 
Table 4.4 Relationship between BMI and age group 
 Age group  
BMI Age ≥ 40  Age < 40 Total 
≥ 30   61 20 81 
< 30  97 72 169 
Total 158 92 250 
 (p = 0.001) 
4.9 Risk of OSAS and gender 
The fourth secondary objective was to compare risk of OSAS with gender. A Chi-square 
test revealed a statistically significant relationship between risk of OSAS and gender. A 
lower risk of OSAS associated with being female (χ2 [1] = 8.32, p = 0.004). This is shown in 
Table 4.5. 
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Table 4.5 Relationship between risk of OSAS and gender 
 OSAS  
Gender At risk  Not at risk  Total 
Male 26 71 97 
Female 19 134 153 
Total 45 205 250 
(p = 0.004) 
4.10 Risk of OSAS and age 
The fifth secondary objective was to compare risk of OSAS and age. A higher risk of OSAS 
is associated with an older age. 
A Chi-square test revealed a statistically significant relationship between risk of OSAS and 
age. A higher risk of OSAS was associated with being ≥ 40 years of age (χ2 [1] = 18.70, p = 
0.001). This is shown in Table 4.6. 
Table 4.6 Relationship between risk of OSAS and age  
 OSAS  
Age At risk of OSAS Not at risk of OSAS Total 
≥ 40 42 116 158 
 < 40 3 89 92 
Total 45 205 250 
 (p = 0.001) 
4.11 Discussion  
Obesity occurence and risk of OSAS in surgical patients at CHBAH had not previouly been 
investigated. It is important to determine these as the anaesthetic management needs to 
be tailored to both these conditions. These conditions also carry an increased morbidity 
and mortality peri-operatively. Screening for high risk can also help identify these patients 
and then provide them with counselling about lifestyle changes and nutritional advice 
they may have not otherwise received.  
There is a paucity of literature on the occurrence of obesity in the surgical population 
globally. This is futher compounded by the fact that many studies were conducted in 
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patient populations that had specific characteristics, for example going for bariatric 
surgery. The global trends of obesity in the general population however, has been well 
studied. This study showed the occurence of obesity in the study population to be 32.4%. 
The United Nations produced a report in 2013 ranking countries in terms of their level of 
obesity. Mexico was ranked first with a 32.82% rate of obesity followed by the USA 
31.83% and Syria with 31.64 % (46). Our population was thus on par with the most obese 
nations in the world 
In 2012 the World Federation of Obesity released statistics showing that 10.6% of males 
and 39.2% of females were obese. In 2002 The South African Demographic Health Survey 
found 29% of men and 56% of women were classified as either overweight or obese. This 
was consistant with our findings of a higher percentage of obese females. 
Factors that should be taken into consideration in our study were that the patients 
sampled were mainly from the South of Johannesburg, the majority being from the 
suburb of Soweto. This is a largely lower socio economic group. It is recognised that as 
communities become more urbanised their rate of obesity increases as unhealthy food, 
high in fat, is often cheaper and more easily available (62). Financial constraints in many 
families lead to diets consisting mainly of starchy carbohydates that are cheaper and 
more easily available. The societal and cultural considerations should also be taken into 
account. In this setting being well fed is reflected by your size and obesity may be seen as 
a sign of affluence and a man’s ability to take care of his wife rather than a health risk. 
Higher weights are also associated with being HIV negative. In the African culture wide 
hips and big buttocks in a woman are seen as desirable characteristics by men and as a 
sign of fertility. Education in this population may also not be optimal. Education about a 
balanced diet, the need for exercise and the risks of obesity may not be well known or 
understood. (50, 51, 69) 
There are few studies internationally  that have attempted to document the occurrence 
of OSAS in the general population. The problems encountered in comparing these studies 
were that different questionnaires and screening tools were used in each study to assess 
the risk of OSAS. There is an incidence that ranges between 9 to 26% among these 
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studies. Very few studies documenting the prevalence of OSAS in the surgical population 
were identified.(4, 5, 20)  
The estimated prevalence of OSAS in the American population is thought to be about 20% 
(4, 5). In the surgical population the risk of OSAS is thought to be higher. Finkel et al (4) 
studied the risk of OSAS in adult surgical patients and found 23.7% of patients to be at 
risk. This study used the apnoea risk evaluation system OSAS screening questionnaire. In 
our study population a risk of OSAS was found to be 18% which was considerably lower 
than that found by Finkel. We did however use a different screening questionnaire. 
It is widely thought that OSAS is under diagnosed (3, 5, 108, 109). Finkel et al’s (4) study 
looked at the prevalence of undiagnosed OSAS and found that 82% of patients screened 
had undiagnosed OSAS. This diagnosis was made based on using home sleep studies. 
Unfortunately due to lack of resources and difficulty in obtaining home sleep study 
devices we could not determine the prevalance of undiagnosed OSAS in our population. 
It was of interest is to note in our study even patients that were not obese, were still at 
risk of OSAS.There were 23 (28%) obese patients who were at risk of OSAS and 22 
(13.02%) non obese patients who were at risk of OSAS. This highlights the point that OSAS 
can be present outside the setting of obesity.Further support of this is provided by a 
Japanese study where Isiguro (110) found that facial skeletal abnormalities could also 
lead to OSAS even in the absence of obesity. 
 
The risk of OSAS is usually higher in males, older age and obesity (111). Our study found 
this to be true with a lower risk associated with lower BMI (p = 0.003) and female gender 
(p = 0.004). A higher risk was associated with age ≥ 40 (p = 0.001). 
 
Although there was a high occurence of obesity in the females there was a lower risk of 
OSAS. Of the females screened 12% were at risk of OSAS compared to 29% of males. This 
could be due to their body habitus. Although there was a greater percentage of obese 
females they carried their weight mainly in the abdominal area, hips and thighs and had 
neck circumferences that were lower.  
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OSAS is a well known association of obesity (19). In obese patients often there are para-
pharyngeal fat deposits that increases pharyngeal collapsibility predisposing to OSAS. 
Increased abdominal wall deposits found in obese patients also decrease lung volumes, 
particularly  functional residual capacity (FRC) which can directly influence upper airway 
size, contributing to upper airway narrowing and predisposing patients to OSAS, which  
affects anaesthetic practice (19) Obesity hypoventilation syndrome also effects the 
control of breathing and further attenuates OSAS. (32) 
Hiestand et al (3) published data from the National Sleep Foundation poll which showed  
that 57% of obese individuals were at risk of OSAS. (3) Our study found that among the 
obese patients, 28% were at risk of OSAS which was significantly lower.  
4.12 Conclusion 
In this chapter the results of the study as defined by the objectives were presented 
followed by a discussion of the results.   
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Chapter Five: Summary, limitations, recommendations and 
conclusions 
5.1 Introduction  
In this chapter a summary, the limitations, reccommendations and conclusions of the 
study are presented.  
 5.2 Summary of the study 
 5.2.1 The aim of the study  
The aim of this study was to describe the occurrence of obesity and risk of OSAS in adult 
patients going for elective surgery at the J.D. Allen and the Gynaecology Theatre Complex, 
at CHBAH  
5.2.2 Objectives of the study  
The primary objectives of this study were to: 
 describe the BMI of adult patients undergoing elective surgery   
 describe the risk of OSAS using the STOP BANG questionnaire.   
 
The secondary objectives of this study were to: 
 compare the BMI with risk of OSAS 
 compare the BMI with gender 
 compare the BMI with age 
 compare the risk of OSAS with gender  
 compare the risk of OSAS with age.   
5.3 Methodology of the study 
A prospective, contextual, descriptive study design was utilised. The study population was 
adult patients presenting to CHBAH for elective surgery in the disciplines of general 
surgery, orthopaedic surgery, plastic and reconstructive surgery, maxillo-facial surgery, 
urological surgery,  gynaecological surgery, otorhinolaryngology and neurosurgery. In 
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consultation with a bio-statistician a sample size of 250 patients was needed to yield a 
sample size of approximately 100 obese patients assuming a 40% prevalence of obesity 
among this population. A convenience sampling method was used. Inclusion criteria for 
this study were adult patients 18 years and older, presenting for elective surgery and able 
to stand upright. Exclusion criteria for this study were patients declining to participate in 
the study and those with any medical condition which increases extracellular fluid and 
thus weight. 
5.4 Main findings and summary of the study 
This study confirms that 3 of the 8 risk factors for OSAS from the STOP-BANG 
questionnaire were present in the sample, namely obesity, age and gender. The 
occurrence of obesity, BMI ≥ 30, was found to be 32.4%. The risk of OSAS using the STOP-
BANG sleep apnoea questionnaire was found to be 18%. When looking at the relationship 
of obesity and OSAS, 28% of obese patients were found to be at risk of OSAS.   A lower 
BMI was associated with male gender (p=0.001) and age less than 40 years (p=0.001). 
Lower risk of OSAS was associated with lower BMI (p=0.003) and female gender 
(p=0.004). Higher risk of OSAS was associated with age ≥ 40 years (p=0.001).  
5.5 Limitations of the study 
The study was contextual and focused only on patients presenting for surgery at CHBAH, 
which services mainly the black population of Soweto. The results of the study may not be 
generalised to other communities.  
 The risk of OSAS was only assessed by using the STOP-BANG questionnaire, and no 
formal diagnosis of OSAS was made, due to financial constraints. 
Convenience sampling was used which may have lead to over or under estimation of 
certain variables in the population. 
The sample size was not calculated to accommodate the secondary objectives. The results 
of these objectives should therefore be interpreted with caution.  
 
61 
 
 
5.6 Recommendations from the study 
 5.6.1 Recommendations for clinical practice 
A high index of suspicion of OSAS in obese and non obese patients must be entertained in 
patients presenting for surgery, as both obesity and OSAS are associated with a higher 
risk of peri-operative morbidity and mortality. Patients should have anthropometric 
measurements routinely done, from which BMI should be extrapolated. Patients should 
also be questioned about snoring and the STOP-BANG questionnaire should be routinely 
used in pre operative assessments. Patients at risk should be treated as having OSAS, as in 
our setting there are no resources to diagnose OSAS and a high proportion of OSAS has 
been found to be undiagnosed. The peri-operative management of these patients must 
be modified to limit the use of opioids and place these patients in a high care 
environment post operatively so that desaturations, hypopnoeas and apnoeas may be 
detected. The patients should also be referred to a sleep physician for further 
management and be counselled adequately about their condition. Obese patients should 
be referred to the dieticians to ensure that they are well informed.  
 5.6.2 Recommendations for further research  
Similar studies carried out at various hospitals around the country will give a more holistic 
view of the burden of disease. While the occurrence of obesity has been identified in a 
previous study in 2002 (50), there is no current data regarding this. There is also no data 
regarding the burden of obesity in the surgical population.  
A study should also be conducted to validate the use of the STOP-BANG questionnaire in 
the South African surgical patient population. 
There are no South African studies identified documenting OSAS, either in the general 
population or the surgical population to assess the burden of disease. More formal 
studies could be undertaken. 
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5.7 Conclusion 
Obesity is a multi-system disease and has far reaching effects on all body systems. OSAS is 
associated with a constellation of problems. Obesity and OSAS are thus associated with 
significant morbidity and mortality. Anaesthetists need to be aware of both conditions 
and actively screen for them. When either or both conditions have been identified it is 
important to carefully tailor an anaesthetic plan to prevent morbidity and mortality. In 
our study we showed that the surgical population have an occurrence of obesity 
comparable to the most obese nations in the world. Our study also showed a risk of OSAS 
of 18% which was comparable to other studies in the USA. Obesity and OSAS is a growing 
concern in our population and more awareness of these conditions and their 
complications needs to be created. 
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List of abbreviations 
OSAS- obstructive sleep apnoea syndrome 
WHO- world health organisation 
CHBAH- Chris Hani Baragwanath Academic Hospital 
BMI- body mass index 
USA- United States of America 
NHS-National Health Statistics  
 TNF α- tumour necrosis factor alpha  
CDC- Centers for Disease Control and Prevention  
REM- rapid eye movement 
ESS- Epworth Sleepiness Scale 
NREM- non-rapid eye movement  
REM- rapid eye movement  
API- apnea hypopnea index  
CPAP- Continuous positive airway pressure 
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Appendix 1: Data collection sheet 
Participant number _____        
  
Gender 
Male  
Female  
Age  
Ethnicity 
Black  
White  
Asian  
Other  
 
STOP- BANG Sleep Apnea Screening Questionnaire Yes No 
1. Do you SNORE loudly (louder than talking or loud enough to be heard 
through closed doors)? 
  
2. Do you often feel TIRED, fatigued, or sleepy during daytime?   
3.  Has anyone OBSERVED you stop breathing during your sleep?   
4. Do you have or are you being treated for high blood PRESSURE?   
5. BMI more than 35?   
6. AGE over 50 years old?   
7. NECK circumference > 15.75 inches? (39.375cm)   
8. Male GENDER?   
≥3 yes answers: High-risk for OSA 
<3 yes answers: Low-risk for OSA 
       
  
Anthropometric data 
Height (m)  
Weight (kg)  
BMI (kg/m2)  
Neck (cm)  
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Appendix 2 : Participant Information leaflet 
Hello, my name is Kamini Naidoo. I am a registrar in the Department of Anaesthetics at 
the University of Witwatersrand. I am currently doing my Masters degree in 
Anaesthesiology. This page will assist you understanding my study. I would like to invite 
you to participate in my research study entitled “The occurrence of obesity and risk of 
obstructive sleep apnoea in adult patients presenting for elective surgery at an academic 
hospital”.  
Before you agree to participate in this study, it is important that you understand the 
purpose of the study and what partaking will entail, and your right to withdraw from the 
study at any time. Should you not understand anything I will happy to answer any 
questions. You should not agree to take part unless you are satisfied about all the 
procedures involved.  
If you decide to take part in this study you will be asked to sign this document to confirm 
that you understand the study. 
The purpose of the study is to find how many people are overweight and snore among 
the patients presenting for surgery at Chris Hani Baragwanath Academic Hospital. The 
study will collect information from about 250 adult patients, patient over 18 years old, 
which need to have routine surgery. This will take about 15 minutes of your time. 
If you agree to take part in this study, you will be taken to a private room where the 
measurement of your weight will be done. How tall you are will be measured. The 
distance around your neck will also be taken. All these results will be written on a page, 
but your name or any of your details will not be written down. These measurements will 
not be painful and will not harm you in any way. A short set of eight yes/no questions will 
also need to be answered. These will give an idea of whether you are likely to snore. 
 This information will help us to better treat patients coming for surgery as being 
overweight and snoring may have increased risk during surgery and anaesthesia.  Should 
you be identified as being overweight you will be referred to the dieticians who will help 
you with a weight management programme.  
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Your participation in this study is entirely voluntary and you can decline to participate, or 
stop at any time, without stating any reason.  Your withdrawal will not affect your access 
to other medical care.  
This clinical study protocol has been submitted to the University of the Witwatersrand, 
Human Research Ethics Committee and written approval has been granted by that 
committee.  
The study has been structured in accordance with the Declaration of Helsinki (last 
updated: October 2008), which deals with the recommendations guiding doctors in 
biomedical research involving human participants.  A copy may be obtained from me 
should you wish to review it.  
This study is sponsored by the Postgraduate Research Office at the University of the 
Witwatersrand, Faculty of Health Sciences. I do not have any financial or personal 
interests with this organisation that may bias my actions. 
All information obtained during the course of this study, including hospital records, 
personal data and research data will be kept strictly confidential.  Data that may be 
reported in scientific journals will not include any information that identifies you as a 
participant in this study. 
 The information might be inspected by the University of the Witwatersrand Human 
Research Ethics Committee (HREC). Therefore, you hereby authorise me to release your 
medical records and the University of the Witwatersrand, Human Research Ethics 
Committee (HREC). These records will be utilised by them only in connection with 
carrying out their obligations relating to this clinical study. Any information uncovered 
regarding your test results or state of health as a result of your participation in this study 
will be held in strict confidence.  You will be informed of any finding of importance to 
your health but this information will not be disclosed to any third party in addition to the 
ones mentioned above without your written permission. 
  
77 
 
Appendix 3: Consent form 
I hereby confirm that I have been informed by the study doctor, Kamini Naidoo, about the 
nature, conduct, benefits and risks of research study “The occurrence of obesity and risk 
of obstructive sleep apnoea in adult patients presenting for elective surgery at an 
academic hospital”. 
I have also received, read and understood the above written information (Participant 
Information Leaflet and Informed Consent) regarding the study. 
I am aware that the results of the study, including personal details regarding my sex, age, 
date of birth, initials and diagnosis will be anonymously processed into a study report. 
I may, at any stage, without prejudice, withdraw my consent and participation in the 
study. 
I have had sufficient opportunity to ask questions and (of my own free will) declare myself 
prepared to participate in the study.  
PARTICIPANT: 
 
Printed Name     Signature / Mark or Thumbprint  Date and Time 
I, Kamini Naidoo, herewith confirm that the above participant has been fully informed 
about the nature, conduct and risks of the above study. 
STUDY DOCTOR: 
 
Printed Name   Signature     Date and Time 
 
TRANSLATOR / OTHER PERSON EXPLAINING INFORMED 
CONSENT…………………(DESIGNATION): 
 
Printed Name    Signature    Date and Time 
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Appendix 4 : Ethics approval letter 
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Appendix 5: Post graduate approval letter 
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Appendix 6:  Permission to conduct research  
 
 
